Knowing Where I Am At : The Experience of Self-Monitoring Blood Glucose for People with Non-Insulin-Requiring Type 2 Diabetes. by Brackney, Dana Elisabeth
East Tennessee State University
Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations Student Works
8-2010
"Knowing Where I Am At": The Experience of Self-
Monitoring Blood Glucose for People with Non-
Insulin-Requiring Type 2 Diabetes.
Dana Elisabeth Brackney
East Tennessee State University
Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Medicine and Health Commons
This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.
Recommended Citation
Brackney, Dana Elisabeth, ""Knowing Where I Am At": The Experience of Self-Monitoring Blood Glucose for People with Non-
Insulin-Requiring Type 2 Diabetes." (2010). Electronic Theses and Dissertations. Paper 1727. https://dc.etsu.edu/etd/1727
 
 
―Knowing Where I Am At‖ The Experience of Self-Monitoring Blood Glucose for People 
with Non-Insulin-Requiring Type 2 Diabetes 
_______________________ 
A dissertation  
presented to  
the faculty of the Department of Nursing  
East Tennessee State University 
 
In partial fulfillment  
of the requirements for the degree  
Doctor of Philosophy in Nursing 
________________________ 
by 
Dana Elisabeth Brackney 
August 2010 
________________________ 
Dr. Kathleen Rayman, Chair 
Dr. Joellen Edwards 
Dr. Patricia Hayes 
Dr. Gary Kukulka 
 
Keywords:  Self-Monitoring Blood Glucose (SMBG), Type 2 Diabetes, Personal 
Knowledge, Interpretive Description, Numeracy, Illness Experience
2 
 
ABSTRACT 
―Knowing Where I Am At‖ The Experience of Self-Monitoring Blood Glucose for People  
with Non-Insulin-Requiring Type 2 Diabetes 
by 
Dana Elisabeth Brackney 
Eleven participants living with non-insulin-requiring Type 2 Diabetes (T2DM) discussed 
their self-monitoring blood glucose (SMBG) experience. All had been recently 
diagnosed (< 2 years) and treated for diabetes with a self-regulating SMBG guideline for 
primary care practice. Their digitally-recorded interviews and photographed logbooks 
were analyzed thematically and interpreted through the lens of numeracy literature to 
answer 2 questions: 1. What is the meaning of SMBG among people with non-insulin- 
requiring T2DM? 2. How do people with non-insulin-requiring T2DM perceive the 
function of SMBG in diabetes self-management? The meanings of SMBG were patient 
competence, ―It is easy, just a little pin prick‖; patient control, ―I can control it. It doesn‘t 
control me‖; and patient security, ―It is not that way anymore.‖ Three periods of lived 
time were observed: Diagnosis ―The numbers say I have diabetes‖; Behavior change ―I 
just can‘t figure out why it does that‖; and Routine ―I make my numbers.‖  Prominent 
numeracy functions emerged by time period. During Diagnosis primary numeracy 
functions included comparing SMBG results to target values. Participants expressed 
this experience as, ―I am some kind of O.K.‖ During Behavior change applied numeracy 
functions included taking medication correctly. SMBG readings were experienced as a 
clue to the diabetes mystery, sometimes confusing the participants, ―I just don‘t know 
why it does what it does,‖ or answering questions, ―Now there is no question marks.‖ 
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Numbers motivated some people for action ―The numbers get me out a walking‖ or 
restraint ―If I didn‘t have the numbers, I would be tempted to cheat.‖ During Routine 
interpretive numeracy functioned to aid the evaluation of the efficacy of participant‘s 
health behavior change. Numbers had taken on meaning helping a person to ―know 
where I am at.‖ Clinical implications are suggested including adjustments to the self-
regulating SMBG guideline for primary care practice. Findings are discussed in relation 
to personal knowledge processes (Sweeny, 1994) and related SMBG research. 
Participants concluded that routine SMBG is essential to maintaining and restraining 
health behavior. This study provides a model for use of SMBG in diabetes self-
management and patient perspectives on SMBG during the 2 years following T2DM 
diagnosis. 
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CHAPTER 1 
INTRODUCTION 
Statement of the Problem 
Type 2 diabetes mellitus (T2DM) is frequently diagnosed in the primary care 
office. The absence of evidence based guidelines for the use of self-monitoring blood 
glucose (SMBG) and the context-dependent use of SMBG contribute to the lack of 
uniform implementation and prescription of SMBG for the treatment of T2DM (ADA, 
2009). With this diversity it is not surprising that studies evaluating the relationship 
between SMBG in T2DM and glycosolated hemoglobin (HbA1c) have demonstrated 
mixed results (e.g. Davis, Bruce, & Davis., 2007; United Kingdom Prospective Diabetes 
Study [UKPDS] group, 1998). A systematic review (Clar, Barnard, Cummins, Royle, & 
Waugh, 2010) of the value of SMBG in terms of glycemic control, hypoglycemia, quality 
of life, and cost per quality adjusted life year leaned heavily on the findings from the 
Diabetes Glycaemic Education and Monitoring study (DiGEM). Researchers concluded 
that SMBG was likely not cost effective due to the absence of evidence that SMBG 
users had a clinically significant reduction (≥0.5%) of HbA1c, a measure of average 
estimated blood glucose (BG) over the most recent 3 months. This systematic review 
concluded that research is needed to determine the type of SMBG education and 
feedback that is most beneficial, characteristics of patients who benefit from SMBG, 
best practice for timing and frequency of SMBG, and the circumstances under which 
SMBG causes anxiety or depression (Clar et al., 2010). With so much unknown about 
SMBG in T2DM, I chose to use a qualitative approach to study the meaning and 
function of SMBG for the person with non-insulin-requiring T2DM. 
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Practice guidelines developed by the American Diabetes Association (ADA; 
2009) recommend using SMBG in T2DM to achieve self-management goals. However, 
not enough is known about how SMBG functions in T2DM to guide efficient use of 
SMBG. For example, the International SMBG Working Group (2007) acknowledged a 
lack of consensus for use of SMBG in T2DM and stated that three factors influence the 
use of SMBG: country of residence, diabetes treatment, and cost. Within the United 
States the ADA guidelines (2009) specify that testing should be sufficient to achieve 
glucose targets (fasting blood glucose (FBG) < 100 mg/dl and 2 hour postprandial < 160 
mg/dl). Standards have not been established for optimal SMBG frequency or timing in 
patients with non-insulin-requiring T2DM using oral agents or medical nutrition therapy 
alone. The ADA guidelines (2009) recommend that SMBG begin in T2DM once HbA1c 
is greater than 6.5%; however, to date the ADA has not provided specific 
recommendations regarding the frequency and timing of SMBG in T2DM.  
In addition to an absence of specific recommendations for SMBG, researchers 
have debated the value of euglycemia. Normal HbA1c is less than 6.0%. However, 
several prominent studies (Veterans Administration Diabetes Trial [VADT], 2009; The 
Action to Control Cardiovascular Risk in Diabetes [ACCORD] study group, 2008) did not 
demonstrate short- or long-term cardiovascular benefits for attaining HbA1c in patients 
with levels less than 6.0% (Duckworth et al., 2009; Skyler et al., 2008). A possible 
explanation for the lack of benefit is that although considered long-term, neither of these 
large studies exceeded 5 years of data collection, whereas previous studies reported 
longitudinal data beyond 10 years.  
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Both the Diabetes Control and Complications Trial (DCCT) and UKPDS have > 
10 years of longitudinal data and researchers concluded that euglycemia was beneficial 
(Diabetes Control and Complications Trial Research Group, 1993; UKPDS Group, 
1998). In Type 1 Diabetes the DCCT study findings included a 76% reduction in eye 
disease, a 50% reduction in kidney disease, and a 60% reduction in nerve disease. In 
T2DM the UKPDS study demonstrated a 21% reduction of risk for diabetes 
complications for each 1% reduction in mean HbA1c. The findings of these newer 
studies (ACCORD, 2008; VADT, 2009) have challenged the vascular benefit of 
euglycemia. As a result, both the ADA and American College of Cardiology have called 
for individualization of glycemic targets because both organizations consider the long-
term effects of hyperglycemia deleterious to cardiovascular and neurological body 
systems (Skyler et al., 2008). The 2009 ADA guidelines recommended a HbA1c goal of 
on or around 7%. This context-dependent guideline demands more skillful application of 
diabetes therapies by practitioners.  
In addition to therapeutic concerns, there is pressure to demonstrate the 
economic benefit of BG testing. The cost of most BG test strips exceeds 1 dollar per 
strip. Because many patients with diabetes qualify for Medicare, diabetes related costs 
consume 34% of the Medicare budget (Diabetes Report, 2008). Currently Medicare 
provides one BG test strip per day to beneficiaries with T2DM who are not using insulin. 
Therefore, prudent use of this resource is necessary. SMBG is likely to come under 
increased scrutiny as health care practices are reviewed within the current environment 
of health care reform, evidence-based practice, and cost containment. Researchers and 
17 
 
ultimately practitioners need to know more about the manner in which people use 
SMBG information to improve metabolic control. 
Today physicians diagnose DM earlier in the disease process due in part to 
increased disease surveillance and changes in diagnostic criteria (ADA, 2007: National 
Institute of Diabetes and Digestive and Kidney Diseases, 2008). It is unclear to what 
extent those who are able to demonstrate metabolic control as evidenced by a HbA1c of 
less than 7.0% are benefiting from SMBG or other management efforts such as earlier 
initiation of medication. The increased number of people with T2DM who are testing 
their BG may not be related to the morbidity of diabetes. Instead, this increase may 
reflect changes in the availability of test materials (Center for Disease Control and 
Prevention, 2007). For example, many manufacturers provide glucometers to 
healthcare providers. These glucometers are given at no cost to patients who want to 
begin BG testing. Providing free glucometers to patients often benefits the glucometer 
manufacturer because patients must then purchase the test strips for the 
manufacturer‘s free glucometer. Therefore, the availability of free glucometers, 
combined with financial reimbursement for testing supplies may contribute to more 
frequent BG testing (Center for Disease Control and Prevention, 2007; Kelly, Ellison, 
Goldstein, Nomura, & Price, 2007; Li, Zhang, & Narayan, 2008). SMBG appears to be 
most effective when combined with intensive diabetes management (DCCT, 1993; 
UKPDS, 1998). In addition to the use of many classes of medication and more frequent 
dosing of medication, intensive diabetes management includes a team of professionals 
coordinating diabetes treatment (Bayless & Martin, 1998). Various diabetes 
professionals such as physicians, registered dieticians, exercise specialists, and 
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registered nurses monitor progress toward individualized goals, while supporting self-
management skills and the personal efforts of people with diabetes (DCCT, 1993). 
Although, SMBG shows clear benefits when used to adjust insulin dosages (common to 
Type 1 DM treatment), it is unclear that testing alone without the benefit of a diabetes 
health team or medication adjustment improves metabolic control. 
In the Australian Fremantle Diabetes Study Davis, Bruce, and Davis (2006) found 
no association between glycemic benefit and SMBG testing or frequency for people with 
T2DM, regardless of medical treatment. The 5-year Fremantle study used a community 
based longitudinal and cross-sectional design (n = 1,286). Kolb et al. (2007) concluded 
that this finding was flawed due to study design confounders with cross sectional 
designs not demonstrating the benefit of SMBG, but longitudinal studies supporting 
SMBG efficacy. This was attributed in part to the generally younger and higher HbA1c in 
those enrolled in the SMBG study compared to the control group. Davis et al. (2007) 
refuted this criticism and provided support for their original determination. However, the 
debate about the benefits of SMBG continues (e.g. Clar et al., 2010; McAndrew, 
Schneider, Burns, & Leventhal, 2007; McGeoch, Derry, & Moore, 2007; Welschen, 
Bloemendal, Nijpels, & Dekker, 2005). 
The purpose of this study was to determine the perceived meaning and function 
of SMBG for people with non-insulin treated T2DM in primary care. In order to improve 
how DM health providers direct the use of this resource, diabetes health care providers 
need more information about how and why people use SMBG information. Knowing 
more about SMBG meaning and function for people with T2DM will likely strengthen the 
efficient use of SMBG. Specifically, this study addresses two research questions: 1. 
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What is the meaning of SMBG among people with non-insulin-requiring T2DM? 2. How 
do people with non-insulin-requiring T2DM perceive the function of SMBG in diabetes 
self-management?  
In this study participants newly diagnosed with T2DM experienced a patient 
focused, self-regulating intervention using a self-regulating SMBG guideline for primary 
care practice (Appendix A). The participants were asked to discuss their experience 
with diabetes and SMBG. Their responses were analyzed to determine their perceived 
meaning and function of SMBG. Although HbA1c is an important measure of the 
metabolic health of participants, the focus of this study is the participants‘ experience of 
SMBG in the 2 years following diagnosis with T2DM. 
Study Significance 
DM is a chronic condition that often increases in severity over time and imposes 
significant personal and economic burden for those living with this disease. One 
diabetes health behavior is SMBG. The direct economic cost of SMBG is over $350 US 
annually for a person with T2DM. Although the direct economic cost is easily measured, 
the personal burden of performing this behavior is variable. Approximately 18% of 
people with T2DM describe DM treatment as burdensome (Huang, Ewigman, Foley, & 
Meltzer, 2007). In addition to personal and financial costs, it is unclear how people with 
non-insulin-requiring T2DM can best use SMBG to improve DM outcomes (McAndrew 
et al., 2007). Broadly accepted as a cornerstone of personal self-care, some believe 
that SMBG was adopted without robust evidence of clinical efficacy (O‘Kane & Pickup, 
2009). People with DM need the most effective and least intrusive treatments. However, 
the efficacious use of SMBG in T2DM has yet to be determined. 
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Assumptions 
My decision to use a qualitative method to study people‘s experience with SMBG 
in the primary care office was influenced by both my experience working with people 
who live with DM and my experience reflecting on and analyzing the qualitative and 
quantitative studies surrounding DM self-management. Diabetes management may be 
more effective over the lifetime of the person with diabetes if behaviors associated with 
learning to live well with diabetes are initiated soon after a diabetes diagnosis. SMBG 
may provide the feedback that people with diabetes need in order to regulate their 
health behavior. 
In every research endeavor there are both implicit and explicit assumptions. 
Beliefs about the nature of knowledge and the area of inquiry influence selection of 
research questions, study design, and methods. Assumptions in this and every study 
extend beyond those that are explicitly stated. Polanyi‘s (1966) essays on the tacit 
dimension and personal knowledge formed the philosophical context of this study and 
formed the basis for this study‘s assumptions. This study assumed that life-context is 
central to the meaning and function of SMBG and that personal knowledge influences 
the meaning and function of SMBG for the person with T2DM. Collectively, the 
assumption of this study was that people use SMBG by applying this information to their 
life-context in a way that is meaningful to them. 
The first assumption was that life-context is central to the meaning of SMBG. 
Life-context is the sum of one‘s past, present, and anticipated future. Life-context likely 
influences the efficacy of BG testing strategies for people with non-insulin-requiring 
T2DM. Today people with T2DM may use SMBG to measure fasting BG, premeal BG, 
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and postmeal BG. People with T2DM have varied life-contexts. Often the only 
commonality evident between people with T2DM may be their diagnosis and treatment 
of DM. Diabetes health care providers advise people to rotate BG testing to different 
meals or times, resulting in broader testing contexts. Thus, people may test their BG at 
a variety of times but only once or twice each day. While some applications of SMBG 
such as preprandial and postprandial testing combined with fasting BG are considered 
more efficacious for metabolic control than fasting BG testing only, all of these 
strategies function to support the individual with diabetes. Diabetes health professionals 
provide BG targets that are dependent on life context. For example a BG of 135 mg/dl is 
considered elevated in a fasting state but is normal in a fed state. 
The second assumption is that personal knowledge, conceptualized as 
experience, appraisal, and rational intuiting, influences the meaning and function of 
SMBG and results in a new pattern of behavior. This study explored Polanyi‘s (1966) 
philosophical understanding of individual experience alongside Sweeney‘s (1994) 
conceptualization of personal knowledge. Three attributes of Sweeney‘s definition of 
personal knowledge were considered: experience, appraisal, and rational intuiting.  
Experience is considered in light of writings and research on illness experience 
(Keogh et al., 2007; Kleinman, 1988). Living well with diabetes requires attention to 
present health behaviors in order to prevent future health complications. People with 
T2DM describe self-management as a fluid experience (Rayman & Ellison, 2004). 
Together these works informed the assumption that the experience of living with 
diabetes influenced the meaning and function of SMBG.  
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Appraisal is considered in relation to self-efficacy and narrative. Self-efficacy is a 
forward looking appraisal, while narrative is a backward looking appraisal. Bandura‘s 
(1986) conceptualization of regulatory self-efficacy and the ensuing years of research 
on diabetes and self-efficacy inform this study‘s conceptualization of appraisal of future 
performance. Narrative is a retelling of one‘s experience (e.g., Broom, 2000; Frank, 
1995). It is a meaning-making activity that communicates one‘s appraisal of his or her 
experience. Together these forward and backward looking appraisals inform this 
assumption that personal knowledge influenced the meaning and function of SMBG. 
Finally, rationale intuiting, a third characteristic of personal knowledge, was 
considered in relation to a person‘s numeracy. Numeracy is the ability to comprehend 
meaning in numerical data. This study explored how people with T2DM interpreted and 
used SMBG information. A glucometer provides users with a BG reading in the form of 
a number. Therefore, numeracy was assumed to be one skill influencing personal 
knowledge of SMBG and the effective application of SMBG in diabetes self-
management. For people with type 1 DM, SMBG informs daily medication adjustment 
and other self–care behaviors (DCCT, 1993). When daily medication adjustment is 
unlikely as in non-insulin-requiring T2DM the experience of SMBG needs further 
exploration to understand how numbers are used for self-management.  
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CHAPTER 2 
REVIEW OF RELATED LITERATURE 
 The Diabetes Control and Complications Trial (DCCT Research Group, 1993) 
was a landmark study in the field of diabetes management. This longitudinal study 
established the causal relationship between hyperglycemia and diabetic complications. 
The study intervention included a multidisciplinary team of diabetes health professionals 
intensively managing patients with T1DM using SMBG. After researchers demonstrated 
the benefit of euglycemia, frequent SMBG became standard practice. This practice of 
SMBG was extended to those with T2DM as well. UKDPS (1998) was the first 
longitudinal study of people with T2DM. Researchers concluded that euglycemia 
benefitted health outcomes in T2DM and they supported the use of SMBG (UKDPS 
group, 1998). Today, with diabetes expenditures crippling health care budgets, the 
question of the cost effectiveness of SMBG, the value of euglycemia, and the function of 
SMBG have prompted researchers to revisit the benefit of SMBG. The following review 
of related literature explores the current health care context and what is known about 
the function of SMBG. In addition the philosophical, conceptual, and theoretical stance 
of this study is reported.  
Health Care Context 
Health professionals often identify the first symptom of DM, fasting 
hyperglycemia, in routine lab work. The majority of people with T2DM have insulin 
resistance combined with insulin deficiency (Fowler, 2010). Obesity is the primary cause 
of cellular insulin resistance. Insulin deficiency results when some pancreatic Beta cell 
function is lost due to age or pancreatic injury. Relative insulin deficiency occurs when 
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the demand for insulin is greater than the supply. Insulin deficiency and insulin 
resistance usually occur gradually during the 10-year period prior to a person meeting 
the diagnostic criteria for T2DM (Fowler, 2010).  
Diabetes Diagnosis 
Prior to receiving test results both patients and providers may be unaware that 
BG levels are elevated. Rarely do patients attribute symptoms (e.g. fatigue, yeast 
infections, thirst) to underlying glucose intolerance or diabetes. In the primary care office 
patients respond to a diabetes diagnosis with disbelief, expressions of guilt, or a 
promise to do better. Receiving a diagnosis of T2DM initiates patients into the world of 
DM self-management. In a recent qualitative study women described feeling that they 
were not given enough information about DM when they were diagnosed (Matthews, 
Peden, & Rowles, 2009). To date no similar studies have been published for men 
diagnosed with DM. 
Treatment for T2DM begins with lifestyle changes directed at weight loss and 
nutritional management (Fowler, 2010). Oral antidiabetic medications are added if 
glycemic values do not improve with lifestyle changes (Fowler, 2010). People with 
T2DM may see their diabetes symptoms disappear when they decrease their 
carbohydrate consumption, thereby lessening the need for insulin. They also may 
increase their activity in order to reduce weight and decrease insulin resistance. 
However, over time many people experience a decreased effectiveness in their initial 
lifestyle changes (Fowler, 2010). At this point medications in one or more classes of oral 
antidiabetic agents (e.g. biguanide, sulfonylurea, thiazolidinedione) are added to further 
improve metabolic control. 
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Diabetes self-management is comprised of daily activities including exercise, 
dietary modification, stress management, and monitoring. The demands of these 
activities may increase in complexity over time. Huang et al. (2007) reported that 
although the majority of the patients surveyed (n = 701) indicated that diabetes 
management was not burdensome, up to 18% of people with T2DM would be willing to 
give up 8 out of 10 healthy years if they could avoid life with diabetes treatments. Many 
diabetes educators consider SMBG a foundation of diabetes self-management because 
prior to SMBG testing people with DM and diabetes educators did not have meaningful 
information about BG response to dietary intake, exercise, or medications. SMBG is a 
tool that people with DM and health care professionals use to evaluate the effectiveness 
of educational, behavioral, and medical therapies.  Although SMBG is used extensively 
in both T1DM and T2DM, its use in non-insulin-requiring T2DM is not clear (McAndrew 
et al., 2007; McGeoch et al., 2007; Welschen et al., 2005). Living well with diabetes 
requires many health behaviors that are believed to improve metabolic control. Diabetes 
self-management is a collection of health behaviors adopted by people living with 
diabetes. Health professionals inform people with impaired fasting glucose or new onset 
T2DM that adopting diabetes health promoting behaviors improves metabolic control 
and contributes to overall health. Although the etiology of T2DM likely has a genetic 
component, many people with T2DM express feeling that their behavior (eating sugar, 
gaining weight) caused their diabetes, and thus their illness was their own fault (Broom 
& Whittaker, 2004).  
The ADA (2007) recommends daily exercise and dietary restrictions for the initial 
treatment of T2DM. These lifestyle changes introduce patients to diabetes self-care, 
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also called diabetes self-management. Initially, depending on the person‘s dietary 
history, he or she is instructed to remove concentrated sweets and limit carbohydrate 
(45-60 grams per meal) and fat consumption (< 30% of total daily calories) (Fowler, 
2010). In addition, depending on exercise and medical history, diabetes health 
professionals instruct the patient to increase activity (usually walking) to 30 minutes a 
day (Fowler, 2010). 
Diabetes Health Promoting Behavior 
American Association of Diabetes Educators-7 (AADE-7™) 
 Over the past decade the American Association of Diabetes Educators (AADE) 
has defined diabetes health promoting behaviors. Peeples, Tomky, Mulcahy, Peyrot, 
and Siminerio (2007) reported in their historical account of the evolution of the AADE-
7™ that the AADE reached consensus on the seven behaviors essential to diabetes 
health promotion in 1997. These behaviors were trademarked in 2006 as the AADE-
7™. The AADE-7™ is healthful eating, being active, monitoring, taking medication, 
problem-solving, healthful coping, and reducing risks (Peeples et al., 2007). In 2006 the 
AADE chose the chronic care model as its practice model (Peeples, 2006). This 
selection further defined the organization‘s theoretical context for diabetes 
management. 
Monitoring 
The AADE-7™ behavior termed monitoring includes daily SMBG, regular 
assessment of blood pressure, and assessment of weight. Although all three are 
important health measures, SMBG is the focus of this review. Glucometer 
manufacturers have worked to improve the ease of use and accuracy of BG testing. 
Two recent improvements in glucometers include devices that do not require manual 
27 
 
coding and those that use a smaller blood sample (< 3 microns). Laboratory regulators 
recommend the use of a control solution to determine the accuracy of the glucometer; 
however, this practice does not account for sample variations due to the person‘s own 
blood sample or testing technique (Arabadjief & Nichols, 2006). 
User and environmental characteristics that may interfere with accurate testing 
include low hemoglobin, hematocrit, mean cell volume, and dialysis (Arabadjief & 
Nichols, 2006). Extreme temperatures interfere with the accurate functioning of 
glucometers and test strips. Obtaining a capillary sample may force cellular components 
to dilute the sample through maceration of the puncture site. Hand lotion and soap can 
interfere with results. Miscoding and improperly stored test strips also contribute to 
glucometer inaccuracy. Some people express doubts about the accuracy of their 
glucometers. When people retest within minutes of an earlier test and obtain a different 
result, conflicting findings weaken their trust in their glucometers‘ accuracy. The 
perceived trustworthiness of BG readings may influence people‘s self-management 
experience (Polonsky & Skinner, 2010). 
Data Management 
 Logbooks and electronic management of BG data have limitations due to the 
contextual meaning of BG readings. In my experience people often find it difficult to 
understand how to enter their readings into logbooks. Electronic data management 
systems need to be checked for accurate date and time stamps. When the date and 
time stamp is incorrect the data stored are much less meaningful. Practitioners are not 
usually paid for the evaluation of e-mailed logbooks or data. It is difficult for people to 
provide enough information about their life context in logbooks. For example a reading 
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at 1:00PM may be after or before lunch. If people do not code the relationship of their 
reading to their meal the reading is less meaningful to the practitioner. Understanding 
the BG context improves the usefulness of BG data. 
The Function of SMBG in T2DM 
SMBG is a specific skill that is easy to perform. Young and old alike are 
physically capable of testing their BG. However, it is the cognitive response to numerical 
information that is challenging. Recently McAndrew et al. (2007) reviewed the efficacy 
of SMBG. Researchers concluded that ―there is a need for studies that implement all the 
components of the process for self-regulation of SMBG to assess whether patient use of 
SMBG will improve HbA1c levels‖ (p. 992). The authors identified seven behaviors 
necessary for implementation of SMBG in diabetes management: 
1. Know how to take a reading. 
2. Understand when the reading is above or below target values. 
3. See the connection between deviant readings and prior behavior.  
4. Have and implement an action plan to control glucose levels. 
5. Rely more heavily on SMBG readings and give less weight to subjective 
feelings of well-being and possibly false signs of hypoglycemic distress. 
6. Create simple action plans that will allow the patient to integrate them into his 
or her ongoing life patterns, the use of SMBG, and the behaviors needed for 
effective blood glucose management.  
7. Evaluate glucose reading in a nonjudgmental framework. (p. 1006) 
These seven behaviors informed the content development of the interview guide 
(Appendix C) for the current study. This study explores the meaning and function of 
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SMBG among participants who experienced a self-regulatory approach to diabetes self-
management.  
Metabolic Control 
Diabetes is a disorder of carbohydrate metabolism. There are now four indicators 
of a diabetes diagnosis (ADA, 2010). The first is a random BG greater than 200 mg/dl 
with symptoms. The second is a fasting BG greater than 126 mg/dl measured on more 
than one occasion. The third is an oral glucose tolerance test with a 2-hour postload BG 
greater than 200 mg/dl. In January of 2010, the fourth indicator, HbA1c ≥ 6.5%, was 
approved by the ADA after an international committee assembled by the ADA, the 
International Diabetes Federation, and the European Association for the Study of 
Diabetes discussed diagnostic parameters for T2DM using HbA1c values (ADA, 2010; 
Saudek et al., 2008). Sandbaek, Lauritzen, Borch-Johnsen, Mai, and Christiansen 
(2005) determined that capillary whole BG and venous plasma glucose were equivalent 
in the identification of disease. Although these values are essential for diagnosis, it is 
impractical to measure BG continually in order to measure an average BG. Therefore, 
the HbA1c is a practical approximation of these values for ongoing measurement of 
metabolic control (Manley, 2008). Impaired fasting glucose, also called pre-diabetes, is 
defined as having a fasting BG greater than 100 mg/dl but less than or equal to 125 
mg/dl (ADA, 2009). Type 2 diabetes mellitus is a metabolic disorder with a single 
diagnostic criterion, hyperglycemia, but a variety of etiologies (Fowler, 2010). 
 HbA1c 
HbA1c measures the overall glycemic control of diabetes. As an outcome 
measure it is diagnostic, evaluative, and predictive of future disease (DCCT Research 
30 
 
group, 1993). HbA1c approximates average BG values over the preceding 2 to 3 
months (Fowler, 2010). Predictive of future health status, 50% of the HbA1c value 
represents the previous month‘s average BG, while 25% represents each of the distant 
2nd and 3rd month‘s average BG (Rohlfing et al., 2000) 
In their recent work, Monnier, Colette, Dunseath, and Owens (2007) described 
the progressive loss of glycemic control in T2DM. They used continuous glucose 
monitoring to examine BG patterns by time of day and created 4 HbA1c groups:  ≤6.4%, 
6.5%-6.9%, 7.0%-7.9%, 8.0%-9.0%. They observed stepwise BG changes between 
groups of people with T2DM classified by HbA1c values. The first significant difference 
was between people with HbA1c values less than 6.5% and those with HbA1c values 
between 6.5% and 6.9%. Those with the higher HbA1c (6.5%-6.9%) had deteriorated 
daytime postprandial BG control. The second significant difference occurred when 
fasting blood glucose (FBG) deteriorated. Those with better metabolic control (HbA1c 
6.5% - 6.9%) had better FBG than those with HbA1c values between 7.0% and 7.9%. 
Finally, those with the highest HbA1c values (HbA1c 8.0%-9.0%) had significantly 
elevated nighttime BG. This observed progression supports the use of HbA1c to guide 
DM treatment plans. Specifically, treatment focused on postprandial BG values may 
benefit patients when HbA1c is above 6.5% despite near normal FBG levels. These 
findings provide a context for using HbA1c levels to guide the timing of SMBG. For 
example if a patient‘s HbA1c is 6.7%, one may assume that fasting BG is not as 
elevated as after meal BG readings. Therefore, focusing SMBG on postprandial testing 
may be more clinically efficacious in this context. 
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Influences on HbA1c 
Although widely accepted as reliable and valid, the use of HbA1c in research and 
practice does have some caveats. First, there are several chemical processes for 
obtaining an HbA1c reading. Different HbA1c analyzers may have results that may or 
may not be comparable across methods (Sacks et al., 2002). Second, the use of HbA1c 
to measure improved DM management may be a function of the time of year at 
measurement instead of a function of the experimental manipulation. Dasgupta et al. 
(2007) confirmed this observation and reported on two other studies and four letters to 
the editor that discussed a seasonal phenomenon in the Northern Hemisphere where 
elevations of HbA1c were observed during winter months and decreases in HbA1c were 
reported during summer months. Third, HbA1c results may vary due to patient factors 
such as hemoglobinopathies, hemolytic and iron deficient anemia, vitamin C and E 
consumption, and hypertriglyceridemia (Sacks et al., 2002). This seasonal variation is 
important because a change in HbA1c of 0.5% is considered significant (Clar et al., 
2010). Researchers could falsely claim or disclaim the significance of their study 
findings due to seasonal variation.  
Targets 
Despite analyzer and individual variation, it is generally accepted that a HbA1c 
greater than 7% places an individual at increased risk for diabetes related complications 
(DCCT Research group, 1993). According to Dhatt, Agarwal, and Bishawi (2005) a 
reading that is less than 6.3% is considered good BG control. The American College of 
Endocrinology and the ADA have identified different goals for HbA1c. The American 
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College of Endocrinology has set a target of less than or equal to 6.5%, while the ADA 
has set the target of less than 7.0% (Jellinger, Lebovitz, & Davidson, 2006).  
In 2008 the ACCORD study researchers randomly assigned 10,000 people with 
T2DM to either an intensive glycemic control group or a standard care group in order to 
evaluate the heart disease imposed by diabetes. However, researchers stopped the 
ACCORD study when the intensively treated group (HbA1c goal < 6.0%, achieved 
median < 6.4%) had a significantly higher risk of mortality than the standard treatment 
group (HbA1c goal 7.0%-7.9%, achieved median < 7.5%). All participants had T2DM 
and two or more heart disease risk factors (The ACCORD Study Group, 2008). The 
cessation of the ACCORD study and the variable standards for the target HbA1c 
demonstrated the absence of clear evidence supporting a specific HbA1c target for 
people with diabetes.  
In addition, the Veteran Administration Diabetes Trial (VADT) study of 1,791 
veterans with suboptimal T2DM concluded that intensive glucose control had no 
significant effect on the rates of major cardiovascular events, death, or microvascular 
complications (Duckworth et al., 2009). The participants in the ACCORD study achieved 
lower HbA1c results than the most intensively controlled participants in the VADT study. 
In their position paper, endorsed by the American Heart Association, the American 
College of Cardiology, and the ADA, Skyler et al. (2008) supported the hypothesis that 
glycemic control early in the course of T2DM benefits coronary vascular disease 
outcomes. In addition, these organizations recommended HbA1c targets less than 7.0% 
and stressed the need for individualized care (Skyler et al., 2008). 
33 
 
HbA1c Knowledge 
In addition to the evidence that near-normal HbA1c may have a negative effect 
on mortality in some subsets of people with diabetes, knowledge of HbA1c values did 
not improve metabolic control. In 2005, the ADA launched a campaign to increase 
awareness of the HbA1c. Heisler, Piette, Spencer, Kieffer, and Vijan (2005) found that 
only 25% of the 686 people who had tested their HbA1c in the past 6 months accurately 
reported their HbA1c value. Heisler et al. determined that no association existed 
between knowledge of HbA1c and a respondent‘s diabetes related self-efficacy or 
reported self-management behaviors. Therefore, although there are many influences on 
metabolic control, Heisler et al. concluded that knowledge of HbA1c is useful, but it is 
not sufficient to improve diabetes self-management.  
Many people with T2DM have difficulty understanding the meaning of their 
HbA1c (Heisler et al., 2005). For this reason HbA1c is a stronger outcome measure 
than a potential influence on metabolic control. The work of Heisler et al. (2005) 
champions a movement away from reporting of HbA1c values to patients. Manley 
(2008) suggested providing patients with an estimated average BG value. This value 
may be more easily integrated into patients‘ understanding of diabetes because it 
contains the same units as the BG reading they use every day. Manley (2008) 
anticipated that this estimated average BG derived from the HbA1c value will lead to 
better understanding of metabolic control by patients and better treatment by 
professionals. The International Federation of Clinical Chemistry and Laboratory 
Medicine regard this estimation as analogous to the estimated glomerular filtration rate 
(Manley, 2008). In addition recognizing that people do not easily interpret their HbA1c 
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values may be an important step towards improving communication of diabetes related 
to health numeracy. 
Metabolic Indicators 
There are several other indicators of diabetes metabolic control including 
triglyceride levels, waist circumference, and daytime postprandial BG. Insulin resistance 
worsens metabolic control by decreasing the sensitivity of the action of insulin on 
peripheral tissues (Fowler, 2010). Two indirect measures of insulin resistance are 
triglyceride values greater than 150 (Nakamura et al., 2008) and waist circumferences 
greater than 102 cm in Caucasian men and greater than 88 cm in Caucasian women 
(Bari, Ostgren, Rastam, & Lindblad, 2006). The BG response to carbohydrate 
consumption varies throughout the day in people with and without diabetes. However, 
BG values greater than 140 mg/dl, 2 hours following a 60 gram carbohydrate meal, are 
believed to contribute to poor metabolic control. Although these measures of metabolic 
control (insulin resistance, glucose tolerance) are useful in the understanding and 
treatment of diabetes, at this time the best overall measure of glycemic control is 
HbA1c. 
Medications 
Anti-diabetic medications are some of the most effective interventions for 
improving metabolic control. The effect of various anti-diabetic medications on HbA1c is 
well documented (Bolen et al., 2007). A single class of medications (e.g. sulfonylurea, 
biguanide) may lower HbA1c by as much as one percentage point (Bolen et al., 2007). 
For example Metformin (a biguanide) alone could lower a HbA1c from 7.5% to 6.5%. 
Although monotherapy is often desirable, combination therapies have additive effects 
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resulting in an additional one percentage point absolute reduction in HbA1c over 
monotherapy (Bolen et al., 2007).  
The factors that influence metabolic control are many and varied. These factors 
include the person and his or her genetic and behavioral disposition, other medications 
such as steroids that elevate BG values, central obesity, smoking, stress, activity, and 
eating habits all of which influence carbohydrate metabolism. The beneficial effect of 
medication for diabetes metabolic control is not disputed. Rather than attempting to 
isolate each of these many influences on metabolic control, the current study seeks to 
examine SMBG holistically in the context of the person‘s experience of living with 
T2DM.  
Personal Knowledge 
Philosophical Foundation 
 Polanyi (1966) in his book The Tacit Dimension, provided the philosophical 
foundation for this study. Polanyi defined tacit knowledge as knowing more than we can 
tell. Polanyi‘s epistemological beliefs define knowledge as containing a functional, 
phenomenal and semantic structure. He also defined an ontological structure of 
knowledge. This ontological structure described knowing as being embodied in the 
physical experience of living.  
Functional Structure 
People exhibit the functional structure of knowing by attending to the proximal 
(unaware) to avoid or in anticipation of the distal (aware) (Polanyi, 1966). People with 
T2DM exemplify this anticipatory functional structure in diabetes self-management when 
they fully integrate diabetes health promoting behaviors into their lives in anticipation of 
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improved health outcomes. Conversely a person who does not change his or her meal 
pattern in order to avoid conflict represents Polanyi‘s avoidant functional structure. 
Some women maintain their family‘s dietary traditions in anticipation of their family‘s 
love and support (unaware). These women want to avoid the conflict that might come 
with change (distal aware). At times people who are not working on changing behavior 
are unconsciously living in a manner consistent with a perceived benefit like love and 
support in order to avoid a perceived loss such as the loss of affirmation.  
Phenomenal Structure 
 Polanyi‘s (1966) second knowledge structure, the phenomenal structure of 
knowing, interprets life events as understanding beyond the naming of the event. It is 
this phenomenal structure that gives meaning. This structure is exhibited by an 
awareness of that from which we are attending to another thing in the appearance of 
that thing (Polanyi, 1966). In diabetes-management people exemplify this phenomenal 
structure of knowing when feelings are given meaning. For example when people see 
an elevated BG reading, they may interpret this as a personal failure. Or people may 
believe that they will become an amputee because of a DM diagnosis. The interpretive 
effort creates meaning from the physical experience of living with diabetes. 
Semantic Structure 
 The semantic structure of knowing is exhibited through attending to the meaning 
of its impact on us in terms of its effect on distal objects (Polanyi, 1966). SMBG results 
exemplify a semantically structured knowledge. In diabetes self-management people 
use SMBG results (as a distal object) that have been given meaning by diabetes 
professionals. A person with diabetes defines a BG as elevated if it is greater than 180 
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mg/dl. He or she may not experience a bad feeling with an elevated reading. In fact, 
many people say they feel better when their BG is elevated. The elevated BG result 
(distal object) imparts a semantically structured meaning of poor future health (elevated 
BG = poor metabolic control = poor future health).  
Ontological Structure 
 Finally, the ontological structure of knowledge occurs when bodily experiences 
translate into meaning. Bodily experiences may be innate and internal actions that we 
are incapable of controlling or even feeling. The ontological structure of knowledge 
occurs when we become aware of subliminal processes inside our body in order to 
perceive outside objects. ―By elucidating the way our bodily processes participate in our 
perceptions, we will throw light on the bodily roots of all thought‖ (Polanyi, 1966, p.15). 
Personal knowledge is expressed in diabetes management when a person says, 
―I‘m diabetic.‖ This expression is an ontological knowledge of the diseased body 
defining the way that people think about life and therefore the way he or she will live. 
Not all people with diabetes come to know themselves in this way. Indeed, people may 
define themselves in other bodily ways, such as equating large size with strength and 
vigor. This ontological knowledge may explain why each person with a diabetes 
diagnosis cannot integrate similar educational or behavioral interventions into his or her 
life in the same manner. 
Polanyi (1966) also discussed the role of pattern understanding. He stated that 
we may lose sight of a pattern by dwelling on the particulars too much. However, ―. . . 
the detailing of particulars, which by itself would destroy meaning, serves as a guide to 
their subsequent integration and thus establishes a more secure and more accurate 
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meaning of them‖ (p. 19). This observation is congruent with the finding that adults use 
estimation in much of their everyday application of mathematical information, as 
reported in the numeracy literature (Ancker & Kaufman, 2007). It follows that an 
estimate may be more meaningful than an exact figure. 
In my diabetes practice I use estimation of patient data to make medication 
adjustments. A patient testing more frequently at times of hypoglycemia or conversely 
following BG closely on a day that hyperglycemia is present easily skews mean BG 
values. The adjustment of medication based on numerical data alone without an 
understanding of context could be devastating to metabolic control. This example 
supports Polanyi‘s statement, ―Speaking more generally, the belief that, since 
particulars are more tangible, their knowledge offers a true conception of things is 
fundamentally mistaken‖ (1966, p. 19). It is with this philosophical stance of looking at 
particulars embedded within their context that this study bases its understanding of 
truth. 
Concept Analysis 
Sweeney‘s (1994) derived definition of personal knowledge provided a 
conceptual definition for this phenomenon. Sweeney defined personal knowledge as: 
Recognition of a new pattern through processing by the human being. 
The processing may consist of any combination of human and 
environmental interaction (experience), rational intuiting, appraisal, active 
comprehension, and personal judgment, all in a setting of departure from 
the current conceptual framework. The personal knowledge may be new 
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only to the individual or to all of humanity. It is the individual‘s perception 
of the personal knowledge which denotes its presence. (p. 919) 
Pattern Recognition 
Accepting Sweeney‘s (1994) definition, pattern recognition is the outcome of 
personal knowledge. Pattern recognition is a clinical skill used by diabetes health 
professionals for adjustment of medications, meals, and activity (Linekin, 2002). Some 
people living with diabetes also recognize patterns in their diabetes management. 
SMBG provides information that informs the appraisal of control over one‘s metabolic 
experience. 
Linekin (2002) assisted DM professionals in pattern recognition by providing a 
table that displayed the interpretation of BG results by time of day. This table included 
possible causes of and possible solutions for high and low BG readings. I have 
observed that people with diabetes appraise these values differently than diabetes 
professionals. For example people will say that their BG is doing well. With further 
investigation they report fasting readings greater than 140 mg/dl, a value most DM 
professionals would define as too elevated. Understanding the process of pattern 
identification and interpretation may be central to understanding the impact that SMBG 
has on metabolic control. 
Personal Knowledge Processes 
Experience, appraisal, and rational intuiting are three of the five processes that 
Sweeny (1994) suggested could be combined to reach a new pattern of personal 
knowledge. Although the other two processes of personal knowledge, active 
comprehension and personal judgment, are not included here as primary processes 
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they will likely be evident within the process of appraisal. It is the interpretation of these 
processes that may influence metabolic control.  
The following review of the literature explores diabetes research in relation to 
these processes. Experience is examined in light of illness experience literature. 
Appraisal of past performance is examined with research on making meaning with 
personal narratives (story). Appraisal of future performance is considered in light of 
research on diabetes and self-efficacy. And finally rational intuition is examined with 
emerging literature on numeracy. 
Illness Experience 
Frank (1995) proposed four body problems that people work to resolve over the 
course of their life. These four general problems are control, desire, body-relatedness, 
and other-relatedness. Each of these four problems has an associated continuum of 
possible responses that in turn create a matrix of ideal body types. For example in the 
general problem of control the continuum of body responses are predictability at the 
highest level of control and contingency when forces that cannot be controlled are at 
work. Recognizing that no one individual would exemplify a single ideal type, Frank‘s 
disciplined body or dominating body were two possible ideal types in response to the 
problem of control. Broom and Whittaker (2004) examined the narratives of 119 people 
living with diabetes. They concluded that meanings of control are at the core of the 
moral discourse surrounding life with diabetes. According to Frank (1995) a desire for 
control is central to the disciplined body. However, Broom and Whittaker identified 
chaos narratives as central in their participants‘ experience. In Frank‘s conceptualization 
of chaos narratives people are unable to act to communicate their overwhelming needs. 
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This combination of the body‘s need for control with the inability to express its need and 
take action towards control likely creates a barrier to self-management. 
Recently researchers have begun exploring illness narratives as an avenue for 
increased understanding of behavior and in order to identify models that explain illness 
experiences (Broom, 2000). In my practice as a Board Certified-Advanced Diabetes 
Manager many people master the physical skill of SMBG testing. However, individual 
application and interpretation of SMBG is variable. Some people dread SMBG. Others 
perform the skill routinely. Some find the BG information helpful. Some only test when 
they believe they will obtain a ―good‖ reading. Others test only when they do not feel 
well. SMBG provides people with their BG value for a moment in time. The individual 
must interpret whether that value is on its way up or down, whether it is high or low, and 
whether he or she needs to take action based on the reading. In sum the understanding 
of the reading is much more complex than the skill performance required to obtain the 
reading.  
Individuals develop personal knowledge of diabetes through SMBG. Kleinman 
(1988) discussed the meaning of illness for people with chronic diseases. He stated that 
meanings ―. . . communicated by illness can amplify or dampen symptoms, exaggerate 
or lessen disability, impede or facilitate treatment‖ (p. 9). For example people living with 
diabetes may realize that eating certain foods elevates their BG. They may observe that 
physical activity decreases BG. However, others may not experience clarity in 
interpreting their readings. They may find no patterns and no explanatory models for 
their BG response. In turn they may feel defeated in their efforts at self-management.  
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Personal knowledge differs from general knowledge. One may know theoretically 
that eating cake elevates BG; however, one may not see this response personally. 
Personal knowledge is a different way of knowing about diabetes. Personal knowledge 
comes from the experience of living with the disease. McAndrew et al. (2007) described 
this knowledge as subjective and stated that it is a less desirable guide than the 
objective BG readings. In contrast the current study examined the person‘s creation of 
meaning for symptoms with SMBG. The subjective symptoms that people experience 
are not invalid; however, SMBG should be used to confirm that the interpretation 
matches the BG reading. The wife of a man with DM told me that, ―Every time he says, 
‗I feel funny‘, I get the juice ready because he is having an insulin reaction.‖ This feeling 
was confirmed with a continuous glucose monitor that clearly demonstrated his rapid 
decline in BG. I am comfortable with this person‘s, ―I feel funny‖ as a measure of 
impending hypoglycemia (phenomenological structured knowing). To disregard the 
confirmed human experience to the deference of numerical data seems incomplete as 
both subjective and objective knowledge provide information necessary for self-
management. 
Self-management literature describes three ways in which people integrate their 
experience with illness and their self-identity: integrating, separating, and vacillating. 
Aujoulat, Marcolongo, Bonadiman, and Deccache (2007) observed that handing over 
control is as important to empowerment as the process of gaining control. They 
described how both ‗letting go‘ and ‗hanging on‘ were important self-processes 
influencing self-management. In their case study, Tilden, Charman, Sharples, and 
Fosbury (2005) described one woman‘s experience living with diabetes. This woman 
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separated her identity from her diabetes and became motivated to self-manage. In 
contrast people who accepted asthma, another chronic disease, as part of their identity 
demonstrated better self-management (Jones, Pill, & Adams, 2000). In these examples 
either holding disease out as separate or integrating disease supported self-
management.  
Rayman and Ellison (2004) studied diabetes self-management among women. In 
their study women ―engaged and adjusting‖ to diabetes management ―expressed a 
degree of success in management and spoke of a life goal and having diabetes in the 
context of their life‖ (p. 908). These women were able to navigate the rules of diabetes 
by approaching management with flexibility and appraising diabetes management as 
―doable‖. They succeeded in preserving their self-identities by holding loosely to 
management ideals. These women vacillated between the demands of self-
management and their life context. The women neither embraced fully nor separated 
diabetes from the self. In this way the literature demonstrated three effective models 
(integrating, separating, and vacillating) of self-management and provided insight into 
the personal knowledge and fluid processes of successful managers of chronic disease.  
Appraisal of Past Experience: Narrative Knowing 
In addition to the specific relationship between SMBG and interpretation of 
readings, the person‘s life likely influences health in ways that may be less overt. Story 
is one means of developing personal knowledge. Many people express their appraisal 
of experience through personal narratives. Over a 10-year period Broom (2000) 
identified 347 patients with both physical symptoms and an apparently relevant story 
that he categorized as: ―(1) Physical disorder with onset apparently associated with 
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significant emotional material or life events; (2) Physical disorder with apparent 
metaphorical or symbolic meaning; (3) Physical disorder with apparent meaning which 
is neither metaphorical nor symbolic‖ (p. 166). Skillful health care providers listen to life 
events and the meaning people find in their stories. These interpretations of the self and 
health may provide an ontological structured knowledge that contributes to people‘s 
success as self-managers. 
Frank (1995) identified narratives common to illness experience. His writing was 
congruent with Polanyi‘s (1966) understanding of the body‘s need for a voice. Frank 
stated that a common bodily response to illness is story; however, story may not reveal 
all personal knowledge. As Polanyi defined, tacit knowledge knows more than can be 
told; therefore, personal knowledge may be unaware and unexpressed. Frank has 
identified four common narrative forms that people use to express their illness 
experiences. These forms included the restitution narrative, the chaos narrative, the 
quest narrative, and the testimony. According to Frank restitution narratives dominate 
our society and tell an illness story with a time sequence such as, ―I found out I have 
diabetes, I still have elevated blood sugar; but, I am losing weight and will be healthy 
soon.‖ The chaos narrative is the opposite of the restitution narrative (Frank, 1995). It 
tells a story of being overwhelmed and lacks a coherent beginning, middle, and end. 
Frank defined the quest narrative as a story that takes the form of accepting illness and 
using it to transform the person‘s life. In the quest narrative people own and express 
their illness experience as a journey. Finally, the testimony differs from the previous 
three narrative forms.  In a testimony people are not reporting on what they saw; they 
report on who they are through their living bodies (Frank, 1995). Frank concluded that 
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being a witness to a person‘s illness narrative is an important means of supporting the 
person experiencing an illness. Researchers identified chaos narratives as central to 
their participants‘ experience of T2DM (Broom & Whitaker, 2004). Being a witness to a 
chaos narrative is the most difficulty in our social context (Frank, 1995); however, these 
narratives are common to the T2DM experience. Learning to recognize and listen to the 
chaos narrative is likely important for practitioners working with people who have T2DM. 
Appraisal of Future Behavior: Self-Efficacy 
Self-efficacy can be considered an appraisal of future behavior. Hurley and Shea, 
(1992) reported that the earliest conceptual work with self-efficacy and diabetes was 
Crabtree‘s 1986 dissertation. Hurley and Shea (1992) demonstrated the role of self-
efficacy and diabetes self-management among individuals with complex insulin regimes. 
Prior to 1986 the role of self-efficacy and health behavior had been studied in relation to 
smoking cessation, weight loss, and rheumatoid arthritis pain management. Since 1986 
researchers have published thousands of studies examining the relationship between 
self-efficacy and diabetes self-management.  
Self-efficacy‟s attributes. Self-efficacy contributes to the process of personal 
knowledge development. Belief not action is the central characteristic of self-efficacy 
(Bandura, 1997). Self-efficacy is a cognitive event that is distinct from action. Thus, 
people can perform health behaviors yet believe that they were not able to accomplish 
these tasks. Self-efficacy is a belief about oneself and one‘s world that has many 
influences on future behavior while also being influenced by the environment, past 
experience, and other people. Efficacy beliefs are variable across several dimensions 
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(Bandura, 1997). According to Bandura (1997) these beliefs differ in level, generality, 
and strength. 
The first self-efficacy dimension, level, is defined as ranging from simple to 
complex (Bandura, 1997). Although researchers have defined health behaviors or 
interventions as simple or complex, no studies were identified that defined self-efficacy 
itself on a continuum from simple to complex (Clark, Hampson, Avery, & Simpson, 
2004; Sturt, Whitlock, & Hearnshaw, 2006). Perhaps it is assumed that simple 
behaviors require simple self-efficacy. Although it appears that the level of self-efficacy 
is closely related to the behavior‘s complexity, this was not discussed in any of the 
theoretical or experimental research.  
The second self-efficacy dimension, generality, can be expressed as general or 
task specific (Bandura, 1997). This dimension was broadly discussed in some of the DM 
research (Rapley & Fruin, 1999; Senecal, Nouwen, & White, 2000; Skelly, Marshall, 
Haughey, Davis, & Dunford, 1995). Rapley and Fruin (1999) examined the relationship 
between general and task specific efficacy to discuss conceptual issues related to self-
efficacy. Experimental studies examined for this review reported task specific self-
efficacy measures (Clark et al., 2004; Gerber et al., 2005; Lorig, Ritter, Laurent, & Plant, 
2006; Siebolds, Gaedeke, & Schwedes, 2006). Bandura (1997) conceptualized a 
bidirectional relationship between general self-efficacy and task specific self-efficacy. 
He theorized that as the strength of general self-efficacy increased, the strength of task 
specific self-efficacy would also likely increase. However, Sousa, Zauszniewski, Musil, 
McDonald, and Milligan (2004) reported that general self-efficacy was a poor predictor 
of behavior.  
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The third self-efficacy dimension, strength, is characterized by the degree of 
tenacity with which one holds to self-efficacy beliefs and results in perseverance 
(Bandura, 1997). Schlenk and Boehm (1998) attempted to strengthen self-efficacy 
beliefs through the use of contingency contracts. Contingency contracts make an 
individual aware of potential barriers to behavior performance while planning to 
overcome these performance barriers. DM health professionals often use contingency 
contracts as an intervention during motivational interviewing. Theoretically, the action of 
planning to overcome barriers increases the strength of self-efficacy beliefs (Schlenk & 
Boehm, 1998). Van der Bijl, van Poelgeest-Eeltink, and Shortridge-Baggett (1999) 
structured the Self-Efficacy type 2 tool to measure the strength dimension of self-
efficacy. Of the three self-efficacy dimensions (level, generality, strength), they 
concluded that strength is a more powerful predictor of self-efficacy than complexity or 
specificity (van der Bijl, van Poelgeest-Eeltink, & Shortridge-Baggett, 1999). This means 
that the perseverance of an individual is more predictive of health behavior than the 
complexity of the task.  
Self-regulating efficacy. In addition to these three dimensions characteristic of 
self-efficacy, Bandura (1997) identified several broad types of self-regulating efficacy 
including initiating efficacy, recovery efficacy, and maintenance efficacy. These 
descriptors of self-efficacy are abstract enough to apply to any use of the concept of 
self-efficacy, but they are especially applicable when permanent behavior change is 
desired. Initiating efficacy is the belief that one can begin to perform a behavior. 
Recovery efficacy is the belief that one can return to the desired behavior if one has 
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stopped performing the behavior. Maintenance self-efficacy is the belief that one can 
continue a desired behavior indefinitely.  
Self regulating-efficacy, with its emphasis on perseverance, appears to have a 
good fit with the demands of a chronic disease such as DM. However, with the 
exception of Determination Theory little has been written about the role of regulatory 
efficacy in health behavior models or experimental studies. Although thousands of 
studies employ the concept of self-efficacy, a 2007 Pub Med search for the related 
concept, regulatory self-efficacy, identified only 106 studies. Only one study of DM and 
the self-regulatory model of illness was identified (Keogh et al., 2007). This family-based 
intervention study is believed to be the first to incorporate evidence from illness 
perceptions research with poorly controlled diabetes (Keogh et al., 2007). Most 
quantitative studies of DM and self-efficacy do not measure the regulatory functions of 
initiating, recovery, and maintenance efficacy. However, qualitative studies have 
described people‘s DM self-management as fluid (Rayman & Ellison, 2004). This finding 
that people with T2DM move in and out of performing DM self-management behaviors 
is consistent with the theoretical descriptions of self-regulating efficacy. The concept of 
regulatory self-efficacy is important to the theoretical perspective of the current study as 
it is an appraisal of future behavior, a process of personal knowledge development.  
Quantitative Knowing: Rational Intuition 
Unlike the ambiguity of self-perception, there is some agreement among diabetes 
health professionals as to the meaning of BG values. Meanings health professionals 
ascribe to BG values are consistent with Polanyi‘s (1966) semantic structure of 
knowledge. Diabetes health professionals provide patients with individualized target BG 
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values based on time of day and in relation to eating and activity. Although the targets 
are somewhat static, the BG number is not static or formulaic. Instead, the quantitative 
information provided by SMBG must be interpreted in the context of a person‘s life. In 
this way and over time a rational activity becomes intuitive (Sweeney, 1994). The 
patient‘s capacity to understand and integrate these values into health behavior requires 
rational intuition. 
Numeracy 
Rational intuition is one process of personal knowledge development as defined 
by Sweeny (1994). Numeracy is the ability to understand numerical information. 
Numeracy informs diabetes self-management. Evans (2000) defined health numeracy 
as the ―degree to which individuals have the capacity to access, process, interpret, 
communicate, and act on numerical, quantitative, graphical, biostatistical, and 
probabilistic health information needed to make effective health decisions‖ (cited in 
Golbeck, Ahlers-Schmidt, Paschal, & Dismuke, 2005, p. 375). Golbeck et al. (2005) 
provided clarification of the numeracy literature by proposing a definition of numeracy 
that encompassed four broad categories: basic, computational, analytical, and 
statistical. Each numeracy category is conceptualized as building upon the other; 
therefore, they are not exclusive. Most numeracy skills used in SMBG are contained in 
the first three categories (basic, computational, analytical). However, even the fourth 
category, statistical numeracy, may be asked of people with diabetes. For example 
people with diabetes may be asked to discuss the percentage of time their fasting BG is 
at their target. Statistical numeracy may be helpful to patients as they predict and 
interpret their pattern of BG in relation to their diabetes self-management behaviors. In 
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this way numeracy influences people‘s ability to use SMBG information for self-
management. 
A 2008 Pub Med search for the concept ―health numeracy‖ identified 61 articles. 
Twenty-three of the articles focused on the evaluation of risk (probability). Eleven 
articles remained when the search was limited by ‗English language‘, ‗age > 19,‘ and 
excluded those studies associated with ‗risk or probability.‘ The earliest article was 
published in 1995. The results included an article on the development of numeracy 
measures (Baker, Williams, Parker, Gazmararian, & Nurss, 1999). The only disease-
specific numeracy studies focused on anticoagulation (Estrada, Martin-Hryniewicz, 
Peek, Collins, & Byrd, 2004) and asthma (Apter et al., 2006). With the exception of 
these examples, the remaining numeracy research has focused on helping people 
understand their risk for disease and their risk for cancer recurrence or survival based 
on treatment options. 
Ancker and Kaufman (2007) evaluated the numeracy literature in the context of 
the entire system of health communication, not ―solely (a product) of the individual 
patient‘s skills‖ (p. 714). Their review considered the verbal communication skills of the 
information provider and the design of information systems (e.g. documents). Altogether 
they identified eight factors of a health communication system that contribute to the 
beneficial use of quantitative information in health management. They recognized that 
numerical ability was distinct from its application for health decision making. For 
example someone with math ability alone would not be able to interpret BG values 
without also understanding the function of diabetes health behaviors on the BG value. 
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DM self-management involves responding to a wide variety of personal health 
information as well as understanding how to translate what is observed into health 
behavior. Estimation and graphical literacy are two skills important to SMBG. Estimation 
is a quantitative skill useful in real-world problem solving. Adults use estimation in many 
day-to-day mathematical calculations such as when they estimate the size of a serving 
of food. Graphical literacy is helpful for use of SMBG logbooks. The ability to place data 
in rows and columns helps patients visualize their data by time of day. Some 
glucometers provide graphs of BG data. Visualizing data with a graph and recognizing 
patterns may assist patients in diabetes self-management.  
In addition Ancker and Kaufman (2007) reported that unlike readability level 
assessments of documents, there are no tools to assess the quantitative demands of 
written communication. Numeracy instruments are available (e.g. Baker et al., 1999). 
However, there are no tools to evaluate the ability of providers to communicate 
information about numbers. Finally, Ancker and Kaufman concluded: 
Our framework suggests that the divide can be narrowed by educating not only 
patients but also information providers. Furthermore, by enhancing the design of 
health-related systems and documents, the informatics community can help 
improve the fit between task demands and individual competencies, helping 
consumers use quantitative information to make genuinely informed decisions 
about health. (p. 719) 
 Schapira et al. (2008) developed a framework for health numeracy after 
analyzing audio and videotaped participants (n=50) in focus groups. Their framework 
was conceptualized as a triangle divided into three sections. The base of the triangle 
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contained primary numeracy skills such as counting and adding. The middle section 
contained applied numeracy skills such as taking medication correctly.  And the highest 
level contained interpretive numeracy. Although similar to Golbeck et al.‘s (2005) 
definition of health numeracy, Schapira et al.‘s hierarchy was unique in its addition of 
the interpretive domain. They defined the interpretive domain  as, ―The ability to 
understand the strengths and limitations of numbers to represent health or disease 
states, the efficacy of an intervention, or other expected health outcomes‖ (Schapira et 
al., p. 507). In addition, the concept of uncertainty, representative nature of numbers 
and recognition of individual or biologic variation in expected outcomes is important to 
interpretive numeracy ability. 
Interpreting BG values is a complex numerical skill to communicate and to 
comprehend. The efficacy of SMBG is likely influenced by both the health care 
provider‘s ability to communicate numerical information and the patient‘s application and 
interpretation of that information. In diabetes self-management, health numeracy may 
improve people‘s decision making and ultimately their metabolic control.  
Summary 
This literature review considered the experience of living with T2DM in the 
context of 20 years of DM self-management research. I examined three areas of inquiry 
proposed to contribute to metabolic control: health care context, DM health promoting 
behavior, and personal knowledge. First, I considered the health care context of a 
person with non-insulin-requiring diabetes. Next, I explored the many contributions to 
and meanings of metabolic control. HbA1c is considered the best measure of effective 
diabetes management, although it is not without limitations. Finally, I considered how 
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illness experience, narrative, self-efficacy, and numeracy contribute to the process of 
personal knowledge development in T2DM.  
In this review I recognized the role of heath promoting behavior for metabolic 
control and accepted the AADE-7™ as a proxy for diabetes health promoting behavior. I 
focused on one health behavior, monitoring (SMBG), and its numeric contribution to 
pattern recognition and the DM illness experience. Several qualitative studies described 
people‘s DM self-management as a flexible experience moving in and out of performing 
DM self-management behaviors (e.g. Aujoulet et al, 2007; Jones et al., 2000; Rayman & 
Ellison, 2004; Tilden et al., 2005). This flexibility is consistent with the conceptualization 
of self-regulating efficacy. Self-regulating with SMBG is believed to influence the 
efficacy of SMBG for metabolic control (Clar et al., 2010). 
This study is important because the experience of learning self-regulating with 
SMBG has the potential to influence the health outcomes of people with T2DM. 
Researchers (e.g. McAndrew et al., 2007; McGeoch et al., 2007; Simon et al, 2008) 
want to evaluate the efficacy of SMBG in T2DM. However, few qualitative or quantitative 
studies (e.g. Furler et al., 2008; Keogh et al., 2007; Siebolds et al., 2006;) were 
identified that examined SMBG in the context of a self-regulating intervention. In this 
study people recently diagnosed with T2DM who had experienced a self-regulating 
intervention using SMBG discussed their diabetes experience.  
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CHAPTER 3 
METHODS 
The research objectives of this study were to describe the meaning and function 
of SMBG among people with non-insulin-requiring T2DM who experienced a 
personalized self-regulating SMBG guideline for primary care practice (Appendix A). 
SMBG is a complex behavior, and its interpretation and application are context 
dependent. The characteristics of complexity and context dependence are congruent 
with qualitative methodology by allowing the exploration of phenomena holistically, while 
also focusing on the human experience (Thorne, Kirkham, & O‘Flynn-Magee, 2004). 
The use of qualitative methodology was implemented in order to avoid early reduction of 
data that may have inadvertently prevented a fuller understanding of the SMBG 
experience for people with T2DM. The choice of this methodology was consistent with 
Polanyi‘s (1966) emphasis on the tacit dimension of knowledge. Polanyi‘s twofold focus 
is on the whole, with a suspicion of the particular for understanding truth and on the 
interpretive effort that creates meaning from the physical experience of living.  
 Approval from East Tennessee State University‘s institutional research review 
board (IRB) was obtained prior to initiation of the study. The researcher informed each 
participant of the study purpose and obtained written informed consent. The consent 
form (Appendix B) indicated that the study investigated the meaning and experience of 
self-monitoring blood sugar, the participants were not required to participate, and if they 
chose to participate, they could withdraw from the study at any time without penalty. All 
participants signed the consent form prior to participation in the study. They were given 
their identification number and the researcher‘s phone number. Participants could ask to 
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be removed from the study at any time prior to its submission to the graduate school by 
presenting their identification number to the researcher and asking to be removed. No 
participants chose to withdraw from the study. 
 In order to maintain privacy during the interview the researcher met with each 
participant in a private room. In order to maintain participant confidentiality the 
researcher maintained one file containing names and the corresponding consent forms. 
This information is stored in a locked file cabinet in the researcher‘s home office. 
Research documents contain an identification number corresponding to each 
participant‘s personal data sheet. Research materials including digital recordings will be 
maintained for at least 10 years in accordance with IRB policy.  
In order to explore the experience of living with diabetes and the use of SMBG, 
the researcher interviewed participants with an open-ended interview guide (Appendix 
B). For example the researcher asked, ―Tell me about being diagnosed with diabetes. 
What is the earliest memory of diabetes that you have?‖ Responses in one interview 
would influence questions asked in a subsequent interview. For example an early 
participant spoke about her fears related to diabetes. Others then were directly asked 
about fears if they did not initiate this topic. In this way the interviews evolved over time, 
although the central questions in the interview guide remained constant for all of the 
interviews. All interviews were digitally recorded. In addition to the audio recording 
participant logbooks were examined for material evidence of the SMBG experience. 
These logbooks were photographed or photocopied.  
In her critique of qualitative description Sandalowski (2009) discussed the 
challenges of characterizing qualitative methods. However, she did not advocate for a 
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particular descriptive method. In contrast Thorne et al. (2004) outlined the objectives, 
mechanisms, and product of interpretive description for nursing research. They 
proposed use of interpretive description for the study of complex clinical phenomena. In 
turn the clinical usefulness of the research product was used as a measure of study 
rigor. In this study thematic analysis and interpretive description were used as research 
methods, allowing the focus of understanding to remain imbedded in the context of the 
participant‘s life even as the researcher worked to understand the meaning and function 
of a given SMBG experience.  
Sampling 
The study participants were people with non-insulin-requiring T2DM managed in 
a family practice office. Theoretical sampling using Monnier et al. (2007) HbA1c 
categories was employed in order to represent the diversity of participant HbA1c levels 
at diagnosis. In this study Monnier et al.‘s third (HbA1c 7.0%-7.9%) and fourth (HbA1c 
8.0% - 9.0%) HbA1c categories were combined and defined as HbA1c ≥ 7.0%. 
Participants in this study were selected based on their HbA1c at diagnosis: ≤ 6.4%, 
6.5%-6.9%, ≥ 7.0%. In addition to their HbA1c, participants were selected if they had 
been recently diagnosed (less than 2 years) with T2DM. People who have had a recent 
life changing experience such as being diagnosed with diabetes are likely to articulate 
their responses to that experience soon after the event differently than they would 
articulate the experience later due to the influence of history and personal interpretation 
(Fereday & Muir-Cochrane, 2006). Therefore, people diagnosed with T2DM within the 
past 2 years or who recently initiated SMBG were invited to participate. Although not a 
cultural group in the traditional sense, the primary care office and its pattern of T2DM 
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management was considered a shared experience for the purposes of this study. 
Sampling continued until data saturation was achieved as determined by the researcher 
and endorsed by the advisory committee. 
Participants 
Fifteen people met the inclusion criteria and were invited to participate in this 
study. Eleven people chose to participate. Two of the four people who did not 
participate had agreed to be interviewed; however, they became unavailable for 
interview due to prolonged family or personal illness. The other two simply declined 
participation. Following study protocol they were not contacted again for inclusion. Of 
the two men and two women who did not choose to participate, one man and one 
woman did not routinely use SMBG. Although this study included one participant who 
did not often use SMBG, the decision not to participate by low frequency testers may 
indicate a different perspective on SMBG that is not as represented in this study. Other 
than this difference, the four nonparticipants had similar treatments and HbA1c levels to 
those who participated.  
The seven female and four male participants were asked to describe themselves. 
Eight of the participants had lived with diabetes for less than a year. The median time 
diagnosed with diabetes was 6 months. The majority was self-described ―country folk,‖ 
whose parents and grandparents had lived their lives in the southern Appalachian 
Mountains. Most participants had farming backgrounds. Two participants had lived more 
than 40 years in the county and were now retired from professional employments one 
as a minister and the other as a teacher. Three participants had more recently (5-30 
years) moved to the area for retirement or employment in a trade such as a house 
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painter. Table 1 presents participant age, HbA1c, and BMI. Three participants were of 
normal weight. Five participants were overweight and three participants were obese. 
The three obese participants were also the youngest participants. The three normal 
weight participants were also the oldest. All participants who followed up had improved 
their HbA1c values (Table 1).  
Table 1  
Participant Age, HbA1c, and BMI (n= 11) 
                   
 
Age HbA1c at 
Diagnosis 
HbA1c at 
Follow-up 
n=10 
BMI 
 
Range 
 
47-73 
 
6.3-9.6 
 
5.5-7.0 
 
22.7-42.2 
Mean 62 7.3 6.2 29.2 
Median 63 6.9 6.1 26.6 
Four participants achieved an improved HbA1c through diet and exercise alone. 
Another three participants used a total daily dose of 500-1500 mg of Metformin along 
with life-style changes such as diet and exercise. One participant was prescribed the 
maximum total daily dose of Metformin (2000 mg). Two participants combined the 
maximum dose of Metformin with either Glimiperide 4 mg or Actos 45 mg daily. One 
participant was unable to tolerate Metformin and used Glipizide 10 mg with lifestyle 
change to achieve improved glycemia. Despite the January end point of the study, when 
seasonal variations historically inflate Hba1c values (Dasgupta et al., 2007), all 
participants demonstrated improved glycemia. 
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Study Setting and Context 
All participants receive their medical care in a family practice office in southern 
Appalachia. These participants live in an area that is considered rural; however, a mid-
sized university is also located within the county. The family practice is staffed by a 
Medical Doctor certified in family medicine, a Physician‘s Assistant, and a Registered 
Nurse certified as both a Certified Diabetes Educator and Advanced Diabetes Manager. 
The researcher developed a self-regulating SMBG guideline for primary care practice 
(Appendix A). The self-regulating SMBG guideline conformed to a structured 20-30 
minute office visit with the Certified Diabetes Educator and focused on patient needs, 
mutually established goals, and diabetes educational principles. Approximately 1 year 
prior to the proposal for this study, this pattern of practice was loosely implemented in 
our primary care office. The self-regulating SMBG guideline for primary care practice 
was adapted to individual patient needs.  
Data Collection 
My work as a diabetes educator and my role in designing and implementing the 
self-regulating SMBG guideline for primary care practice meant that I was both a 
researcher and an object of my study. Therefore as part of my data set, I reflected on 
my diabetes practice and wrote memos each week for 1 month prior to my data 
collection with participants. I discussed these written reflections with my advisor prior to 
beginning data collection.  
Personal Knowledge 
In my practice I have heard many people‘s explanatory models for their diagnosis 
of diabetes. People living with diabetes value these stories, and I am honored to have 
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witnessed them. During the first visit to my practice a patient usually addresses the 
unspoken concern of ―why do I have diabetes?‖ Having witnessed people struggle to 
understand their questions of ―why me?‖ and ―what is diabetes,‖ I often use SMBG to 
help each person define his or her diabetes story. One way I use SMBG is to help 
people confirm their diagnosis. In this way I have had a likely influence on the 
participants‘ stories that I studied.  
Following IRB approval I invited five people in each of the three HbA1c 
categories to participate in the study based on their recent HbA1c levels as documented 
in their medical records. Once selected they were given a letter of invitation and consent 
documents describing the purpose of the study. The following week a research 
assistant contacted people by phone and invited them to participate by stating the 
purpose of the study and reminding them that there was no penalty for nonparticipation. 
Participants were asked to bring their glucometers and logbooks to the interview at a 
mutually acceptable interview time.  
Monnier et al.‘s (2007) HbA1c categories informed the theoretical sample. This 
included four participants with HbA1c ≤ 6.4%, three participants with HbA1c 6.5% - 
6.9%; and four participants with HbA1c ≥ 7.0%. After obtaining informed consent, the 
participants answered demographic questions and provided a participant self-
description (Appendix D). Then I conducted a semistructured interview with an 
openness to interrogate topics that the participant brought to the interview. For example 
some participants had questions about other medical tests or needed prescriptions for 
blood glucose testing supplies. Some also talked about smoking cessation or the death 
of family members. I spent time listening to these concerns and addressing participant 
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needs. While the topic of SMBG was unlikely to create strong emotional reactions, 
participants were reminded during the interview that they were not required to continue 
if the conversation created discomfort for them. None of the participants appeared 
distressed or asked to stop the interview. Seven participants brought glucometers and 
logbooks; these were photographed or photocopied. Written notes about the logbooks 
and photocopies of the logs were made of selected materials. 
Data Analysis 
Data analysis began with the writing of memos following the first participant 
interview. The memos generally took the following form: analytical notes including self-
critique, impressions of significance, common and unique themes, and topics to 
investigate further. Notes were made during the interview and afterwards with an 
emphasis on other areas to explore in the subsequent interviews. Participants were 
asked to clarify or expand on their statements.  Tentative findings or experiences were 
directly clarified or explored with later participants.  
The digital recordings were transcribed verbatim following each interview. In 
addition photos and copies of BG logbooks were examined for further understanding of 
the diabetes and SMBG experience. Once transcripts were completed segments of text 
that contained units of meaning were highlighted using the comment feature in Microsoft 
Word 2007. I analyzed the recorded interviews by coding units of meaning using the 
constant comparison technique. I conceptualized this analysis as vertical within the 
individual interview. After the completion of the 11th interview, I performed an analysis 
that I considered horizontal. This analysis began by clustering units of meaning across 
interviews to form 21 themes. I continued to analyze the recorded interviews by coding 
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units of meaning using the constant comparison technique, at the same time focusing 
on the whole of the life story that the participant discussed. After clustering the units of 
meaning, I discussed thematic groupings with my advisor. Next, general and unique 
themes from all the interviews were selected and formed into a composite around three 
broader time periods in the diabetes experience: SMBG and diagnosis, SMBG and 
behavior change, SMBG and routine. In addition, the photos of logbooks were 
examined as documents and contributed to the data set of participant‘s SMBG 
experience. The visual data were compared to the narrative data for similarities and 
differences and incorporated into the analysis. Finally, an interpretation of the SMBG 
experience was developed and represented using participant language and theoretical 
groupings (Figure 1). In this way logical consistency was demonstrated through a step-
by-step analytical process in formulating themes from participant data (Fereday & Muir-
Cochrane, 2006). 
This interpretation was placed in a diagram and shown to five people who had 
participated in the study and one person who had also experienced the self-regulating 
SMBG guideline for primary care practice (Appendix A) but had not participated in the 
interviews included in the study findings. The diagram included participant language and 
illustrated SMBG functions with flow chart symbols (Figure 1). Participants were also 
provided with a list of SMBG meanings derived from the data. They were asked to 
consider their experience and how it was similar and different to the interpretation. I took 
notes on their responses to the diagram and SMBG meanings. The section Considers 
was first represented with ―It is just a mystery to me.‖ Three participants said, ―It wasn‘t 
a mystery to me. I knew why I had it.‖ Although they applied this statement to the period 
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of diagnosis, and this statement was intended to reflect the beginning of behavior 
change, in order to clarify the diagram, this representation was changed to Considers ―I 
just don‘t know why it does that.‖ The new language was adopted after Figure 1 was 
shown to a participant with both the revised and original language. Figure 1 was folded 
vertically to emphasize the two distinct time periods (diagnosis and behavior change) 
represented in the diagram and the word choice was further discussed with a 
participant. This is one example of developing congruence between the researcher‘s 
constructs and the experience of common-sense in the everyday life of participants 
(Fereday & Muir-Cochrane, 2006).  In this way adequacy of the model was supported. 
Future adoption of the findings in nursing practice will be further evidence of adequacy. 
Finally, the data are presented in Chapter 4 (Findings) with the participants‘ own 
language directly quoted with acknowledgement of the context surrounding each 
narrative. This representation of the data and findings demonstrated rigor by preserving 
the participants‘ subjective interpretation. This rigorous and iterative process of 
interviewing, concurrent clarification and exploration of both spoken and unspoken 
experiences of SMBG, self-reflection, thematic analysis of transcripts, comparing and 
contrasting interviews, generating findings, member checking findings, returning to the 
interviews and summarizing each as a whole resulted in a descriptive interpretation of 
the experience of SMBG for people with non-insulin-requiring T2DM who experienced a 
self-regulating model of care using SMBG. This description included findings of both the 
meaning and function of SMBG for self-management in the 2 years following a 
diagnosis of T2DM. 
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CHAPTER 4 
FINDINGS 
In this study all of the participants shared a recent experience of being diagnosed 
with T2DM. They were introduced to SMBG in a primary care office. The sample was 
theoretically selected based on the participant‘s HbA1c at diagnosis. The HbA1c 
provided an approximation of the physiologic variation in the pattern of deteriorating 
euglycemia.  
Deterioration of postprandial hyperglycemia precedes deteriorating fasting 
hyperglycemia in those with the lowest HbA1c (Monnier et al., 2007). It was anticipated 
that this physiologically observed difference between HbA1c groups would influence the 
SMBG experiences of those who otherwise experienced a similar diagnosis and 
treatment. Surprisingly, those with the lowest HbA1c (≤ 6.4%) expressed more concern 
over unexplained fasting hyperglycemia than those with the highest HbA1c (≥ 7.0%).  
Based on Monnier et al.‘s observation that fasting hyperglycemia deteriorated in the 
6.5%-6.9% HbA1c group, the lowest HbA1c group (≤ 6.4%) would likely observe 
postprandial hyperglycemia prior to fasting hyperglycemia. Participants seemed to 
accept that eating would elevate their BG. However, it was the fasting BG readings that 
caused concern in the HbA1c ≤ 6.4% group. Indeed, those with the lowest initial HbA1c 
(≤ 6.4%) values expressed less acceptance of their diagnosis when compared to those 
with the highest HbA1c (≥ 7.0%). In addition to the influence of HbA1c on the diabetes 
experience, the experience of having or not having family members with diabetes 
appeared to shape participants response to diagnosis. Despite these observed 
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variations, the narratives surrounding the diagnosis of diabetes were similar across the 
theoretically determined groups.  
The narratives and logbooks provided rich data to answer the research question: 
What is the meaning and function of SMBG among people with non-insulin-requiring 
T2DM? Because most participants had recently been diagnosed with diabetes, the 
meaning and function of SMBG was integrally related to the experience of being 
diagnosed and to initiating health behavior change.  First, the diagnosis of diabetes was 
either expected or unexpected. The diagnosis itself was experienced as a ―shock‖, a 
―relief‖, or a ―wake-up call‖. Participants worked to find an explanation for why they had 
diabetes. It was in this context that SMBG was introduced to the participants. Several 
participants explicitly stated that because of diabetes they no longer felt invincible. 
However, most were able to easily perform the SMBG test, and this made them express 
statements of competence. Participants who struggled to believe they had diabetes 
reported that SMBG confirmed their diagnosis by removing, ―question marks.‖ As the 
experience of diabetes created a fear of loss of health, SMBG functioned to comfort 
participants when they were able to ―see‖ their readings and know they were ―some kind 
of O.K.‖ As participants worked to understand their readings, SMBG readings 
confronted them with questions like ―what is it about your digestion or whatever makes it 
do that?‖ In addition SMBG caused them to consider new information in a variety of life 
situations, sometimes surprising participants that ―one little item could make it go so 
high.‖ When people changed dietary and activity behavior, SMBG congratulated their 
efforts by rewarding them with improved BG values, ―I just feel real happy when I make 
my numbers.‖ Participants did not want to test less than once a day if they could afford 
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test strips. To them SMBG meant they were in control and doing something about their 
health behaviors, ―It is not that way anymore.‖  For these participants with non-insulin-
requiring T2DM SMBG meant ―I am competent‖, ―I am in control‖, ―I am doing something 
about it‖, and ―I know it is not that way anymore.‖ Furthermore, SMBG functioned to 
confirm diagnosis ―the numbers say I have diabetes‖; comfort ―I am some kind of O.K.‖ 
and ―I like to know where I am at‖; cause consideration of health behavior ―I just don‘t 
know why it does that‖; and congratulate ―I am doing something about it.‖ (Table 2). 
Table 2 
SMBG Meaning and Function 
 
Meaning Function 
I am competent. 
I am in control.  
I am doing something about it. 
It is not that way anymore. 
It confirms my diagnosis. 
It comforts me. 
It causes me to consider my behavior. 
It congratulates me. 
 
Diagnosis 
Experience: “I am no longer invincible.” 
For many the diagnosis of diabetes meant no longer feeling invincible. One man 
said, ―Well it was kind of I thought, I was almost invincible.  I didn‘t think it would happen 
to me.‖ Likewise, a woman said:  
I think all of us, probably in a little sense, want to be invincible. But then when it 
comes to roost at our doorstep, it is a little different because you hear people 
having this or that or doing this or that. You hear these stories about these 
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people who have to… taking 3-4 shots a day 3-4 pills a day. You think, ‗I don‘t 
want to be there.‘ I mean, it is good if it‘s there because I need it [medication]; but 
I don‘t want to be there. 
 “Unexpected” or “In the Back of My Mind” 
 Although most participants were surprised by their diagnosis, those without 
diabetic family members and those of normal weight were especially unsuspecting. A 
participant without diabetic family members stated, ―I always have had that stereotype 
thing that you have to be fat. There is nobody in the family that has diabetes, on my side 
of the family.‖  Another participant said: 
 Well it was… it was very strange because I am the only one in my family that is 
diabetic. My grandparents were not. My parents were not; of course they died 
very young. My mother was 47 and my dad was 52. So [pause]  and I have no 
cousins. But no, I have no cousins or anything. 
 In contrast other participants with family members who had diabetes spoke of 
wondering if they would be diagnosed. ―My mom had diabetes, and I always wondered 
if I would get it.‖ Others knew they were at risk but were still hopeful that they would not 
―get it‖: 
Maybe you will be this generation that gets skipped. Maybe my sister had it and I 
won‘t get it. You think, you really, you think about the possibility, but then you 
kindly sweep it under the rug and hope it doesn‘t happen. But I have lived like I 
say, and had it in the family for basically all my life, or a big part of it, since I was 
a child. My father lost both legs. Probably a lot of it was from diabetes, but he 
had circulation problems, too. 
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 Others described putting the thought of diabetes in the back of their minds. ―I put the 
whole concept in the back of my mind, knowing that my mother died with it.‖ In addition 
another participant described being both surprised and suspecting: 
I guess I was surprised, but my family has a history of it, so you almost wonder if 
in your life sometime, with it being kind of a hereditary thing, if it wouldn‘t happen. 
It is something you never want to hear, because it can change your lifestyle. 
One female participant was not shocked but did not welcome the news of her diabetes 
diagnosis, ―I have really lived with the concept and seen about it, and I have a sister 
that‘s insulin dependent diabetes. It is not really a shocking thing, but I didn‘t want it.‖ 
Despite the knowledge of their risk most of these participants still experienced a 
combination of surprise and an acknowledgement that they had expected a diagnosis of 
diabetes. In this way expecting a diagnosis of diabetes was most often related to the 
context of family members with diabetes. However, it was the diagnosis itself that 
brought that distant thought out in the open and into the person‘s consciousness. Many 
people also identified the cause of diabetes as genetic, and this along with the high 
incidence of diabetes influenced their perception of personal responsibility for their 
health. ―Well, for one, it is something that I inherited. So, you know, I don‘t take the 
blame. I would take the blame, if I totally ignored all the advice. Then, I think the blame 
would be on me…‖ 
 “A Shock”, “A Relief”, “A Wake-Up Call”, “A Cold-Hard Realization” 
In addition to being shocked by the diagnosis, most participants reported being 
surprised because of a lack of symptoms that they identified as being related to 
diabetes prior to the diagnosis, especially when no family members had diabetes, or 
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when participants had normal weights. Most participants had no bodily symptoms that 
foretold their diagnosis. Only two people reported symptoms of diabetes, and they had 
the highest initial HbA1c readings. This participant expressed how she would have 
recognized her symptoms as diabetes if she had known more about diabetes. ―I had it, if 
I had knowed better the symptoms really well.‖ Another participant said, ―I am just 
thankful it was caught when it was because it could have went on and done damage to 
me.‖ In addition for some participants finding an explanation for symptoms brought 
simultaneous feelings of ―relief‖ and ―devastation‖: 
It was kind of devastating, but also kind of a relief. Because, that is why I am 
getting tired and that is why and my breast is sore right now, and they said that 
could be a sign of being overweight and having sugar. 
Despite not recognizing diabetes related symptoms, many participants reported feeling 
significantly better once their hyperglycemia improved. However, the relationship 
between their bodily symptoms and the diagnosis of diabetes did not immediately 
present itself to the participants. Later as participants reflected on how they felt before 
and after diagnosis and treatment, some were able to see this connection between 
disease and symptoms. 
Participants also interpreted the diagnosis experience as a ―wake-up call.‖ Here, 
three different participants described how this wake-up call was also a call to action:  
So, it [diabetes diagnosis] was a wake-up call, I think, to change some habits. 
  
Yeah, it is kind of a wake-up call, you think, OK we want it 80 to 110 or 70 to 110, 
and here you‘ve got 140 or even 130, that is not acceptable. 
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I hope that maybe it [diabetes] will extend it [life]. I hope that this is a, what do 
you say? I don‘t know, maybe this is a real, cold, hard, realization or something. 
Maybe it [knowing about diabetes and changing lifestyle] will extend it [life], 
because I do have enough gumption to make a difference. 
 
Often participants followed initial descriptions of shock, unwelcome diagnosis, 
and loss of invincibility with stories of amputations and the death of people they knew 
and loved who also had diabetes. A common expression was that diabetes was a 
―death threat.‖ One participant explained how this threat structured her initial response 
to the diagnosis:  
This was sort of like a death threat at the beginning, and so you really did 
everything boom, boom, boom, you know? But then you feel ahh. It is not like 
your cholesterol. It is not like your blood pressure. I mean I can feel when my 
blood pressure goes up and down. But this sort of is sneaky. 
Another participant said, ―You know, [pause] it comes down to a point that it can kill you, 
you know?‖ and another male participant said: 
It isn‘t like a terminal thing but you should be aware of diabetes, and what the 
traits are and test for family history and that sort of stuff too. I put the whole 
concept in the back of my mind, knowing that my mother died with it. She had 
diabetes. 
 One younger participant considered his life trajectory based on his diagnosis and 
anticipated living a shorter life: 
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They all had diabetes. They all had heart disease. I don‘t, I can‘t think of anybody 
from the past couple of generations who has lived past their mid 60‘s. Yeah, that 
was my frame of mind. Well, I figured that is how much time I have left, about 20 
more years or so.  
One participant described her response to being scared by her diagnosis: 
A time to “Look to the Lord for strength”. It really scared me. Well, for a while, I 
was just really confused. And, I don‘t know, I guess I run my blood sugar up, you 
know, with everything that was going on with my eye, and that the cancer in my 
family, and everything else. I usually, you know, look to the Lord for strength. And 
He has give it to me. I lost a son back in the year 2000. I couldn‘t have got 
through that without the Lord. Carried me the day of the funeral. I just I knowed I 
couldn‘t do it. My son had 3 little boys, and I knowed I had to be strong for them 
and for my husband. And I couldn‘t have without the help of the LORD. I knowed 
[sic] then that He could get me through whatever come into my life. Because… it 
is losing a child… it don‘t matter if he is 37…it don‘t matter how old they are, they 
are your baby. So anyway, I do look to the Lord a lot for help and manage to deal 
with all the things that comes on [home]. He has been a real strength for me. 
As this narrative illustrated a diagnosis of diabetes was often a time when people 
reflected on other losses in their lives. In addition to the death of this adult son, two 
other women told stories about the deaths of teenage daughters. Participants who told 
stories of loss usually presented these narratives as a quest (Frank, 1995). In these 
examples the quest narrative ended with participants reporting being stronger because 
of their life difficulties. Participants evaluated their diagnosis with diabetes as a threat 
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but considered the experience of other life-difficulties as a resource for adapting to a 
change in health status 
Many people indicated that the fear of amputations or death motivated them to 
pay attention to their own diabetes: 
My husband used to work with somebody who was a severe case. He ended up 
dying of it. They were amputating more and more you know of his toes and feet 
and stuff like that. That was the worst case I have ever seen. He was really sick. 
Another participant said, ―My father lost both legs. Probably a lot of it was from diabetes, 
but he had circulation problems too.‖ One participant clearly identified her fear of 
amputation along with the reassurance her nonsmoking provided: 
Of course now, I don‘t want to have my leg amputated, and things like that, so 
there might be some of that fear in the background, I could see that that is a 
possibility. I don‘t smoke and stuff which my dad did which attributed [sic] to that, 
but I am sure the sugar diabetes did not help, I don‘t want that. 
One participant discussed a personal knowledge of the dangers of diabetes: 
Yeah, it sure is because like I said, you know, I saw so many of my daddy‘s 
family loose limbs. And right now, my last aunt that is left has got an infection in 
her leg; so, she is not doing real well, and so yeah I know the dangers of it. 
The knowledge of a health threat was often combined with the feeling of no 
longer being invincible. In the following narrative a woman who valued ―family taking 
care of family‖ described her decision to return her diabetic father to nursing home care 
because she did not believe her care was adequate. As the narrative developed she 
illustrated that the health professionals did not know how to help her father either. In her 
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opinion she recognized symptoms of impending health threats and impending death, 
not the health professionals: 
 “I saw him suffer more than I ever saw anyone suffer”. Then I got my daddy out 
of the nursing home, and I was taking care of him. His big toe started turning 
black and I done everything. Health care nurse looked at it. So, I thought well, if I 
put him back in the nursing home, the doctors and nurses will know what to do 
about that since I can‘t do it. So, anyway, he ended up in the hospital with no 
circulation in his paralyzed leg, and they took it off. And they took that leg off, and 
then his bowels blocked up, they had to do a col… what do you call it? 
[Colostomy] Yeah, I stayed with him at the hospital when he was in bad shape, of 
course. Then, one day I went up to see him, and he was doing fairly well. I went 
to see him. He was rubbing his leg, and he said it hurt. So, I looked and there 
was a blue place on it. So, I called the nurse in and showed it to her. She said 
they would take him down and X-ray it, ―It probably warn‘t [sic] anything.‖ But, it 
was on the same leg with his black toe. So, I barely got home they called and 
said, ―You have got to give us permission to take that leg off. He has got gastric 
gangrene.‖ So they had to take it off plumb up to here [points to thigh]. They 
couldn‘t sew it up or anything. And he went on like that a little while, and then I 
noticed a bump, a place on his forehead; it looked kind of like what was on his 
leg. And he suffered terrible during all that. I know for three weeks straight I just 
lived at the hospital. Anyway, I asked the doctor about that on his head because I 
knew it looked like. ―It is just an ol‘ pimple‖ but then, he said ―You go on home 
and get some rest.‖ And I said, ―NO,‖ and I went and picked up my paycheck 
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from work, and went back to the hospital, and he died in just an hour or two. So, I 
saw him suffer more than I ever saw anyone suffer. Now, I heard of his brothers 
and sisters and what they went through, having limbs taken off and stuff. And my 
grandma had it, but she got pneumonia and passed away before the sugar really 
got to her. 
In summary the participants came to the experience of being diagnosed with 
diabetes with a variety of life experiences. While my approach focused on 
communicating about diabetes in a nonthreatening and problem solving manner, most 
participants perceived diabetes as a threat, and many perceived diabetes as a death 
threat. One participant who did not accept his diagnosis did not appear to be as 
threatened as the other participants. Perhaps this was in part because he had survived 
a traumatic head injury from which he had been told that he would not recover. In 
contrast to his previous experience diabetes did not threaten him. Those participants 
with family members living with diabetes had background awareness that someday they 
might also develop diabetes. However, this awareness was still mixed with an element 
of surprise or disappointment that they had developed diabetes. All of those without 
family members with diabetes were not expecting the diagnosis. These participants had 
a more difficult time accepting the diagnosis and trying to understand why diabetes was 
happening to them. In all participants, both those with and those without family 
members diagnosed with diabetes, the SMBG helped to confirm that they had a 
problem with their blood sugar. The moment of diagnosis was also a time of reflection 
on other health concerns (Table 3).  
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Table 3  
Health Concerns of Participants 
 
Health Behavior Health Measures Disease experience Diabetes Related 
Diseases 
Smoking Cessation 
Mammogram Study 
Cholesterol level 
Blood Pressure  
Prothrombin Time 
Family violence 
Sexual Abuse 
Mental Illness 
Head Injury 
Seizures 
Arthritis 
Cataracts 
Heart disease 
Coronary Artery 
Disease 
Peripheral Vascular 
Disease 
Cancer 
Death 
Amputations 
Blindness 
Kidney Failure 
Death 
 
Diagnosis was a focused time of considering health behavior and disease 
experience. Participants spoke of other health and healthcare experiences that they 
thought about following a diabetes diagnosis. Meaning and function of SMBG during 
this experience of ―I am no longer invincible‖ is discussed below. 
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Meaning 
“I am Competent” 
 Three participants had previous experience testing other people‘s blood sugar 
using a glucometer. A fourth person had seen a meter but had not used it. One 
participant had used one of the earliest blood glucose monitors with her father: 
I remember we got my dad a meter, and I was the chosen vessel to check his 
sugar. I remember to get the book out. And the first ones, if you remember, were 
sort of like computers. They were big and, and they were different, and it seemed 
like everything had to be so precise. You better put the blood then, or you better 
forget it and get another strip. I can remember doing that and that was probably 
in the 70s or something, so um, but they kept getting better and my mother kept 
getting… they would update them and get better and better. So the ones now are 
so simple. 
Another participant had worked as a certified nursing assistant and used a 
manufacturer‘s call service to clarify her meter‘s instructions: 
Yeah, I got the [name-brand meter] down. It is really good. I had to call and ask 
them because it had been so long since you know, and meters back years ago 
were different than they are now. I had to call them and ask which end of the strip 
to put in where and how to drop of blood on the side. I got that one. It warn‘t [sic] 
hard . . .  
The BG testing experience was completely novel for six of the participants. 
Learning to perform SMBG was easy for all but one participant. He described his 
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experience as being complicated by a needle phobia and illustrated the bodily response 
―twinge‖ that he experienced. He stated: 
I came into the office and they showed me to do it. I never really did test before 
that. I have always had a phobia about needles that is why I never did do it too 
much. Well I still do but [pause] [―Is there anything that helped you with that-- fear 
of sticking yourself?‖] I, well it is not really a fear, I just don‘t like it. It is just like a 
twinge. I don‘t [pause] a lot of times it doesn‘t really hurt. It is like your insides just 
tighten up. 
At least two participants used alternate site testing. The use of the palm was found to be 
less painful: 
Well ah it is kind of fun, I think, when you can see how your body is reacting to 
different things. It was not painful because you gave me one you can do in the 
palm of my hand, instead of my finger tips, because I really don‘t like finger tip 
pricks. 
Seeing blood was another concern that one participant experienced. ―You showed me 
how easy it was. And the little pin prick. And I liked that because I really don‘t like to see 
blood.  So the little pin prick and how easy it was to do.‖  Two participants limited their 
testing due to cost. The majority of participants wanted to test more than the current 
Medicare provision of one strip per day. Participants spoke in a confident tone about the 
initial learning to SMBG. Although pain, fear of blood, and cost concerns were included 
in the narratives in general participants talked about the ease of testing and that they 
liked the memory feature of meters. The experience of SMBG and the ease of testing 
helped participants feel that SMBG meant, ‗I am competent‘.   
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Function 
Confirms Diagnosis 
 The diagnosis narratives contained one major difference between the 
theoretically sampled participants. The participants with the lowest HbA1c levels had 
the greatest doubts about their diagnosis. In general, the use of SMBG facilitated 
acceptance of the diagnosis intellectually although at least one participant in this group 
continued to struggle to accept his diagnosis. The participants all demonstrated fasting 
BG values > 125 mg/dl. One participant illustrated the function of confirming diagnosis 
when he said, ―Well, the machine says [I have diabetes], and like I say, I have a family 
history on both sides, my father and mother.‖ In addition another participant spoke of 
how testing answered the question, ―do I have diabetes?‖  
―The numbers say I have diabetes”. Yes I have this. No, no, no, there is no 
wonder anymore because you can see it [BG readings] flopping up and down. 
Now it‘s like, OK I don‘t know why I got this; but, it is alright to have because it is 
controllable. 
 A third person explained how testing removed ―question marks‖ through SMBG. ―I was 
very comfortable right away. It was like OK now there is no question marks [sic]. You 
know. You can sort of do the finger stick and see.‖ One participant described how she 
―played it safe‖ in response to conflicting information about her diagnosis of diabetes: 
The doctor that I was going to said, ―OK you are diabetic you have got to go on 
medication‖ and what not, because it was 6.9. Then I went to my OB/GYN [he or 
she] said, ―That is ridiculous you are not diabetic till your A1c reaches seven.‖ So 
I had conflicting opinions as to whether I was diabetic. I figured, if one doctor said 
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yes and another one said no, I would rather be on the safe side and start the 
medication than to not and have the A1c keep going up and up and up. So I 
started the diet and the medication at that time, to play it safe. 
Later this participant described how testing helped make her feel secure. The 
comforting role of SMBG was important because the diagnosis of diabetes frightened 
many of the participants. 
Comforts 
 Beyond confirming the diagnosis, SMBG comforted people who generally were 
anxious about their readings. SMBG supported people with T2DM by allowing them to 
see how their bodies responded to health behaviors. In a moment they could achieve a 
glimpse of what was happening inside their bodies. When people ate moderately they 
could immediately see the improvement on their blood glucose. In contrast change in 
body weight as a result of moderate eating can take weeks or months to achieve.  
Most of the participants expressed ways in which testing improved their anxiety 
related to diabetes being out of control. People used the SMBG for security. Most found 
the information helped them know where they were and this provided a feeling of 
comfort. One participant explained how she moved her testing to a time when she could 
more reliably achieve a ―normal‖ reading because these readings made her feel more 
secure: 
I don‘t know what I would do without it. Let me see if I can explain why. First of all 
I think it is a safety gap. Second, even though I write down all the food. Umm. It‘s 
important to have some idea. Like if I have had a really bad 2 or 3 days.  I like to 
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do the lunch time just to know that there is some time in my day when it is 
normal.  
All participants had been asked to test twice a day on 3 days a week and not test for 4 
days. Most people did not like this schedule of testing because it made them feel 
uneasy on the off days. They liked to see if they were ―O.K.‖ 
„”I am some kind of O.K.”. I am not good at this idea. I would like some level of 
consistency. Whether this number is higher or lower, at least once a day I like to 
know what it is. And feel some kind of O.K. if it is high, or if it is low, or if it is just 
in-between. Why did that happen and what can I do to keep it that way tomorrow 
the same? Come down? Three days without a reading, I would not do good. I 
would not do well. 
Another participant responded with her desire to test three or four times a day:  
No, really I like to be sure it is in the range that it needs to be in. Well, I think 
about three to four times a day, if I could get the strips to do it with. Because, like 
I said, I saw what it could do and I don‘t want mine, to [be out of control]. 
This man did not want to move to testing twice a day on 3 days a week either: 
I don‘t know. I don‘t know being so new to it. I was comfortable doing it three 
times a day. Because, I guess, being new, I was scared that one day it could be 
way up there out of sight. I was a little bit uncomfortable moving to three times a 
week. Just because of that. I don‘t think it would hurt anybody to test once a day.  
It wouldn‘t bother me in the least. 
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Most participants wanted to test more frequently than the self-regulating SMBG 
guideline for primary care practice (Appendix A) recommended. Wanting to test more 
frequently was often related to the desire for reassurance that BG readings brought.  
Although most participants indicated a desire to test more often, one man stated 
that he was not testing according to the self-regulating SMBG guideline for primary care 
practice because he often forgot to test. In addition, two women were not testing 
according to the self-regulating SMBG guideline for primary care practice due to cost 
concerns. In the following narrative one participant described how the cost of testing 
―closed a door‖ for her. She was not currently testing her blood sugar due in part to not 
wanting to file an insurance claim. Avoiding a claim would prevent her insurance 
company from having knowledge of her diabetes diagnosis. 
SMBG costs. I would say the thing that is shocking is the price. I actually looked 
it up online to see if I could find refills. I could get it cheaper on e-bay. But, even 
like at Wal-Mart, it was horrendous, even like a dollar a prick. That takes the fun 
out of monitoring yourself. You know that is so expensive. You are curious, and it 
is fun to see what your body is doing at that kind of a price. You have to pay for it 
yourself. The misuse because I am sure they are not that expensive to make. I 
think it discourages people that are not known by the insurance company to have 
this disease to not monitor where they could. I‘d say at least once a day to get an 
idea of my readings. If it is consistent for a second week, I think you do less and 
less and less. I think I would be curious to see if I am shaky what does it do? The 
different kinds of readings. That door kind of is closed because of the horrible 
price. 
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Behavior Change 
Experience: “Figuring it Out.” 
Participants spoke passionately about how SMBG made them aware of their 
health behavior. Here a man discovered that he was ―wasting‖ food as he chose to eat 
smaller portions: 
I am really starting to see how much food I was wasting. Not necessarily wasting 
but eating that I didn‘t need. That is starting to show up now. I am pretty 
surprised at how much I was eating that I really didn‘t need to eat. Well, for 
instance day before yesterday we had spaghetti you know with, instead of 
hamburger or pork, we had chicken and spaghetti sauce And most of the time, of 
course  my son has moved out too… to the college; but, before it always took at 
least 2 jars of spaghetti sauce and a pound or two of hamburger. And a day 
before yesterday she‘s goin‘, ―I am not sure I cooked enough spaghetti.‖ Well 
when it was all said and done when she, me, and my daughter had already ate. 
There was food leftover. We have a lot more leftovers now than we did. We are 
cooking less and still having leftovers that we didn‘t have before. It just came as 
a shock to me how much I was actually eating and all I can say is it was being 
wasted and turned into fat. 
  Many participants provided examples of how SMBG taught them about the foods 
they ate. This man discovered that juice contained a lot of sugar: 
I know after I eat it is going to be a lot higher. I don‘t know really what range it is 
going to run to. But what surprised me the other day is that I come home and I 
hadn‘t really eaten and I drank some grape juice and I thought I would take my 
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blood sugar  and it was like pooh 130 something and I said, ―Why was it so 
high‖? Well I drank that grape juice. So there must be a lot of sugar in it. 
This woman described how she worked with SMBG to figure out what foods maintained 
her blood sugar in a normal range while considering other nutritional goals related to 
cholesterol: 
Well, the main thing is to find the foods that keep your blood sugar in the normal 
range. That has been my main goal. I wish someone could give me a list and you 
know a breakfast menu, a lunch menu and so on… but you know you kindly have 
to figure that out for yourself because everybody eats different. I do eat meats 
sometimes you know the lean meats. So, and I know that cheese and things like 
that the carbohydrates ain‘t bad; but, it is bad on your weight and it‘s hard on 
your cholesterol. Which mine, cholesterol, is hereditary and it runs it always runs 
high. 
Here a man surprised by an elevated blood glucose reading following a meal described 
how he figured out that the choice he made had elevated his blood sugar: 
The last time, it was after eating barbeque and I was thinking. I thought I did 
good. ―Don‘t eat the French fries, don‘t eat the hushpuppies. Don‘t eat this.‖ 
[pause]  Barbeque sauce. I should have gotten the vinegar base.  I should have. I 
didn‘t think none about that. I am not going to do that again. No, now you learn I 
should have known, I didn‘t think. 
Here a participant described how SMBG surprised her and taught her that even one 
food could elevate her blood sugar. ―I was surprised at somethings [sic]. That they went 
84 
 
so high on the level. Just thinking about one little item could really…I have been 
changing the way that I eat.‖ 
A common experience and confusion for people newly diagnosed with T2DM is 
the role of dietary carbohydrates in elevating blood sugar. This woman talked about the 
experience of discovering by reading a book that carbohydrates, not just sugar, were 
limited in a healthy diet: 
Like I said, the main challenge is to really get settled on the kinds of foods you 
need to eat and the portions and if you can have something. I know in that book 
It said that you could have a tablespoon of jam and you know, I always thought 
the main thing about diabetes was not to eat no sugar I didn‘t know about you 
didn‘t need all them carbohydrates. So the books was [sic] really informative 
about things like that. 
In this narrative a woman described her experience with her treadmill. She found it 
much more difficult to use than she had expected. She described her confidence in her 
commitment to using it as a 5 on a 1 to 10 scale. She was actively trying to find a way to 
integrate use of the treadmill into her life by improving its location: 
Let‘s give it a five. I have done the treadmill. It is really more difficult than I 
thought. These people on TV make it look like you can just get on there and run. 
Like run a marathon and it is so easy, But that is not true. That is a false concept. 
[laughing] I found out the treadmill was rather difficult at least when I have tried it. 
So we are going to get it out and see if we can… We found a new place to put it 
a little bit better place. We had it… we had a wood fire. We had it in there but it 
was too hot. So we are going to take it into another place and see what happens. 
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We had this for a little while and we have used it. (Does it go too fast for you or is 
it on an incline?) I don‘t know. I think I thought I could do like those people on TV. 
I think they blew my mind because I thought, ―man this was going to be easy you 
just get on there and swish swish, sh‖. And it is not that way. But um we‘ll work 
with that. 
In addition to learning about food and activity, this participant described how 
using SMBG led to her discovery that stress elevated her blood sugar: 
Yeah, Yeah I know the morning I had eye surgery. They checked it at the 
hospital before surgery and I hain‘t [sic] eaten anything and it was 178 so when I 
got back home. You told me to check it and so I did and it was around 112. So I 
do know that stress... One morning I checked it that was right after I came to see 
you and I got the testing supplies and my husband and I were in [Town name]. I 
don‘t know why I was stressed maybe it was because he was a driving. But I was 
supposed to check it 2 hours after breakfast. Well, we was sitting in the mall 
parking lot and I checked. It was three-hundred and thirty-three. That is the 
highest it ever was with me testing. 
Meaning 
“I can control it. It doesn‟t have to control me”. Finally, more than half of the 
participants reported that testing gives them a feeling of control. ―Well, It [SMBG] makes 
me feel like it don‘t have to control me I can control it now.‖ This is the second meaning 
identified from the narratives, SMBG means I am in control. Participants experienced 
moving beyond diagnosis and entered the experience of considering behavior change 
and some people eventually established a routine. 
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Function 
Considering Questions   
Many participants indicated that SMBG answered questions they had about their 
body‘s response to eating certain foods, exercising, or being under stress. All of the 
participants wondered ―How am I doing?‖ Testing helped them answer that background 
question. ―I like testing twice a day. It would keep me more in contact with how I was 
doing. If I skip days, then I really in my own mind I am wondering, ‗How did I do today?‘‖ 
Testing answered a question about the effectiveness of treatments: 
O.K., I think we discussed that when I came in and it was 6.5 that I needed to do 
it daily, twice a day and get some readings so we could go from there about how 
to actually see what we needed to do. We discussed Metformin, medication or 
something. But, we decided to let it [pause] see what we could do with diet and 
exercise could do. 
Several participants would document their explanations of elevated readings in logs: 
I usually write down why I think it would have been that high on the extra 
information. I can‘t remember now what it was but umm, it well, after I ate I didn‘t 
get too many high ones after, well I guess it depends what you would call high. 
For many people testing clarified their understanding of the relationship between their 
behavior and their SMBG result. 
Sometimes participants could not think of an explanation for their readings. This 
was very confusing for them: 
Sometimes you think, you know, I have checked it and I think, ―I don‘t understand 
this.‖ Because I find usually in the morning if I do it when I first get up, fasting 
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blood sugar is higher. I don‘t understand it. I think, ―I haven‘t had anything to eat 
since last night. Why is it higher?‖ Sometimes I feel like I have done something 
wrong that makes that. But, I have asked other people and they seem to find that 
too. 
And: 
Well I think the morning testing is always too high and it don‘t matter what I eat 
for breakfast and that if it, you know when I test it 2 hours after breakfast and it is 
too high that pushes me to do the walking and you know better watch my foods. 
Even though I don‘t think that I am eating something bad. I think the only meal I 
tested it before I eat was breakfast and it was always too high. 
And, ―normally it is in range and maybe every now and then it would be a little higher or 
a little lower. That kind of surprises me because I just can‘t figure out what is causing it.‖ 
Testing did not answer questions for several participants, ―I just couldn‘t figure out why it 
would do that and how your digestion or whatever happened would do that.  So, 2 hours 
after you are almost the same as before.‖ Testing created confusion for another man: 
You know I was real confused the other day when I asked you, ―Why, when I eat 
certain things, I have such a reaction now?‖ and you explained it to me. I didn‘t 
have a clue. Why now all of a sudden I could tell when I ate too much sugar. Six 
weeks ago I didn‘t have an idea.  I knew very little until now.  
In addition to clarifying or confusing participants, testing caused this participant to 
consider the question, ―Why was it [BG] so high?‖: 
But what surprised me the other day is that I come home and I hadn‘t really 
eaten and I drank some grape juice and I thought I would take my blood sugar 
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and it was like poo 130 something and I said, ―Why was it so high?‖. Well I drank 
that grape juice. So there must be a lot of sugar in it. Well, it kind of makes me 
wonder you know what should I be eating? What not to eat and, you know? It just 
makes me wonder about that. 
 And another participant described the blood sugar response as a mystery: 
Well, it just makes me more conscious about what I eat. As far as testing, it is 
just a mystery to me. ‗Why is it up this high? Why is it low?‘ because I feel the 
same. I have to figure out what is causing it. What I eat or what I don‘t eat 
[pause] A lot of times I had questions about why even though a lot of times I 
could tell if my blood sugar was up. 
Although much of the wondering is about elevated blood glucose, the following is a 
narrative about hypoglycemia. Without SMBG this kind of active learning would not 
easily take place. 
“And I don‟t know why it does that”. Well it and it happens sometimes at night. I 
will wake up and I‘ll know it is low, I will wake up and be kind of jittery or shaky 
and I will check it and it will be like 60-65 or something. Sometimes it will be 2 or 
3 o‘clock. I check it a lot before I go to bed just to make sure I am ok before I do 
go to bed you know And it doesn‘t happen very often maybe a couple of times a 
month or so once a month. And I don‘t know why it does that [pause] don‘t know 
why it does what it does.  I will check it sometimes a couple of hours after I eat 
dinner and it will be like 110 and most of the time it is O.K. When I get up in the 
morning, It will be I will check it before I eat breakfast and It will be 90‘s 89, 90, or 
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something like that. And then sometimes when it‘s that way. Like I say, when it 
goes low, I don‘t know why it goes low. I never figured that out.  
Here a woman illustrated the mental work of trying to make sense of unexpected 
blood sugar readings: 
I could trace it to something I ate. Sometimes it wasn‘t [related to eating] and I 
know for a long time I was wondering why. Because I discovered along the way, 
probably very early on, if I got on my bicycle, my exercise bicycle not a real 
bicycle, I could go 20 minutes. I could bring it down 100 points. But then I didn‘t 
understand why if I didn‘t eat anything after that why it would still go back up over 
night. But I guess your stomach is still digesting stuff and it is still going through 
you. I guess that is why. 
Participants were actively working to understand their SMBG results: 
I usually write down why I think it would have been that high on the extra 
information. I can‘t remember now what it was but umm it [pause]. Well after I ate 
I didn‘t get too many high ones after, well I guess it depends what you would call 
high. 
Few of these participants stated that they could tell when their blood glucose was 
elevated: 
I was O.K. if it was, I would like it to be under 100. I checked it sometimes after I 
had eaten to see [pause] But I haven‘t done that in a while. I don‘t think that I can 
tell when it is high. Or maybe it has never been high for me to tell. 
Interpreting the readings was also made difficult for participants when they found 
multiple target ranges printed on diabetes related written materials. ―Some of the books, 
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I asked for a book when I lost that one. They gave me a different one and it had a lot 
higher readings to be O.K.‖ 
People searched for explanations for their readings. It was unsettling for people 
to obtain readings they could not explain. The most confusing readings for participants 
were elevated fasting readings. People questioned the reliability of their meters when 
they could not explain the result. The most important use of testing as reported by 
participants was the information meters provided them about how food impacted their 
blood sugar control. In addition testing kept them in contact with how their body was 
responding to life experiences and health behavior. In this way SMBG strengthened 
personal knowledge for health behavior change. 
Contemplating Behavior Change 
 Although the comforting role of SMBG was ongoing across the illness 
experience, one woman described her consideration of transitioning from testing for 
comfort to testing for behavior change. This consideration came about in part due to the 
decreased availability of test strips: 
Now it is trickier with only one [test strip], much trickier from my point of view, 
because one gives you nothing. One just says, ―O.K. I am here right now‖. And 
what do I do to keep it? So now I am beginning to say I can‘t do it before lunch 
because I always know before lunch I‘m pretty good. It is always the same. What 
good is that doing me? 
In addition to keeping participants in contact with how their blood glucose was generally, 
SMBG was also used to help participants understand the effect of different behaviors 
specifically: 
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First to me when I was able to get more [test strips] it helped me to know when I 
did something, whether it was eat a certain thing or [pause], it helped me to know 
what the results were. I can remember telling you that I needed more in order to 
know that. That was probably the most helpful thing that I did, is to do it [testing] 
more often to see how different things affected me. 
This participant also used the readings to make food choices: 
Well, I like to do it in the morning before breakfast so I know where I am starting 
out and that kind of gives me an idea of what I can eat that day. And then I do it a 
couple of hours after lunch a couple of hours after dinner. But I‘ve. You know, 
you just have got to know what it is. Like I say if I could tell by how I felt when it 
gets high, but I can‘t, I don‘t know, I can tell when it gets low but I can‘t tell when 
it gets high without testing. 
These decisions were not made with a formula. Instead people estimated how much to 
eat based on personal beliefs and experience with SMBG. 
Participants most often discussed SMBG in relation to how it informed dietary 
changes. However, stories of the impact of stress and exercise on blood glucose 
readings were also told by the participants. Self-monitoring itself changed eating habits 
in ways not previously known to this investigator. The anticipation of testing blood 
glucose 2 hours after a meal prevented snacking. One person also seemed to believe 
that she had to eat in order to test her blood sugar. She had a pattern of not eating 
breakfast or lunch and so she often ate in order to test her reading 2 hours afterward. 
In addition to dietary, activity, and stress management behaviors, participants 
discussed their experience with smoking. Both smokers and former smokers were 
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proud of their current smoking or nonsmoking behavior. One participant currently 
smoking had once quit during a workplace supported smoking cessation program. After 
a stressful experience she returned to smoking but stated she smoked less than other 
people she knew and told stories of others who were more addicted to smoking than 
she. Two of the men discussed the role of smoking in their workplace. A quitter told how 
he encouraged others he worked with to ‗find the right time‘ to quit. A smoker told how 
he smoked a cigarette only at work. Smoking behavior was discussed in relation to 
family members and farming. 
Motivators. Participants began to consider health behavior change as they 
adjusted to their diagnosis of diabetes and learned about their body‘s response to their 
health behavior. The forces that enable change for any one individual may vary over 
time or from person to person. Participants had intrinsic and extrinsic motivators for their 
health behavior (Table 4). The intrinsic motivators included internal processes. Extrinsic 
motivators included the SMBG numbers combined with a desire to achieve BG targets 
and short-term goals such as losing weight for an event.  
Table 4  
Health Behavior Motivators 
 
Intrinsic Extrinsic 
Determination and self-talk. Special events. 
Fear of DM consequences.  
Fear of ‗being a burden‘.  
Personal satisfaction with achieving BG 
targets. 
Elevated BG values.  
BG keeps DM ‗out in the open‘. 
Knowledge of people with DM related 
amputations or death. 
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People had varied motivations to make lifestyle changes but a common theme 
was ―made up my mind‖: 
You just have to make up your mind that you are just going to do that. It is just a 
different lifestyle of eating. I mean you have got to change the way you eat. You 
have just got to get to the point where you can do that. It is not a, I mean, you 
can‘t just turn it on. You have got to work at it. Yeah it does, it takes a while. 
People who were actively engaged in lifestyle change expressed a feeling of 
determination to control their blood glucose despite challenges such as eating out in 
restaurants or a desire to return to previous eating habits. ―I just feel determined to keep 
it under control. Like I said, I am a pretty determined person. My granddaughter called 
me ornery.‖ One strategy a patient used was self-talk, ―I made it yesterday. I can make 
it today.‖ Despite this seemingly strong determination, when asked how committed they 
were to a health behavior, participants who were actively engaged in behavior change 
indicated that they were committed ―midways‖ or a 5 on a 1 to 10 scale. In this way 
even those who were determined demonstrated the ambivalence or distrust of their own 
commitment and the challenge of maintaining behavior change.  
In addition to a determination to change, a fear of the effects of diabetes, ―I don‘t 
want to be a burden‖, motivated participants: 
Well, I was aware of a lot of the consequences. I knew about the amputations 
and I knew that it affected your eyes, I already had glaucoma I didn‘t want 
anything else. It affects um well it affects your whole lifestyle. I want to be as 
healthy as I am able to be for as long as I am able to be that. I don‘t want to be a 
94 
 
burden for my family. I went through that with my parents. And I choose not to do 
that, if there is any way I can. 
The numbers themselves and the reminder that they brought of the consequences of 
diabetes out of control motivated this participant to maintain blood glucose control: 
Yeah, the readings if they are too high it means you know if I don‘t try do what 
my diabetic nurse says and what I knowed [sic] I need to do; than I could end up 
like my daddy and you know that is why I want to do everything I am supposed 
to… to keep my blood sugar levels down. And ah, I just know how terrible the 
blood sugar, what kind of shape it can get you in. And ah, I really want to keep it 
under control. 
This participant described how self-satisfaction and fear worked together to 
motivate her weight loss: 
I wanted to prove to myself that I could. You know that [pause] of course now, I 
don‘t want to have my leg amputated and things like that, so there might be some 
of that fear in the background, I could see that that is a possibility. I don‘t smoke 
and stuff which my dad did which attributed [sic] to that but I am sure, the sugar 
Diabetes did not help, I don‘t want that. I guess you could say that it is a little bit 
of fear. But then I wanted to prove to myself that I can accomplish this. I know 
still there is help there if I try my best or [pause] and then it doesn‘t work. 
This desire to prove one‘s ability to achieve euglycemia was a powerful intrinsic 
motivator.  
Although SMBG was one extrinsic motivator, this female participant identified 
another motivation for her health behavior change, a reunion with her son: 
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I had another motivator. I had a son that I hadn‘t seen in 2 years and I felt very 
fat and I wanted to be [pause] feel better about myself. So that was a good 
motivator too. I just wanted to lose 10 pounds before I saw him again. Because, it 
is here. It is everywhere actually; but especially in my face. I see pictures on my 
old driver‘s license and the new one. You can definitely see there is a difference. 
I feel better about myself not being as heavy as I was. 
The experience of living with T2DM included situational events that come and go and 
may account for variations in commitment to change. 
Participants‘ narratives provided numerous examples of how SMBG functioned to 
support their health behavior change. Many times adopting new health behavior began 
with a moment of insight experienced with SMBG. Participants then experimented with 
SMBG in their life context and with new health behaviors in order to ‗figure out‘ how 
their body responded. During ‗routine‘ participants spoke about how SMBG functioned 
to maintain their new health routines. People expressed a satisfaction when they could 
‗make their numbers‘. Several participants reported that ‗numbers made‘ them take 
action for their health benefit. Participants reported both intrinsic and extrinsic factors 
that motivated their health behavior. The most common explanation for motivation 
involved the intrinsic characteristic of becoming ―determined‖ or being ―stubborn.‖ In 
addition to these self-descriptions, many participants told stories of other people with 
diabetes. These stories became a type of intrinsic motivator when participants stated. ―I 
don‘t want to end up like…‖ One participant described an upcoming special event as a 
motivator (extrinsic). Once again the extrinsic quality of SMBG, ―keeping diabetes in 
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sight‖, was important to behavior maintenance and the readings themselves got at least 
three participants, ―out walking.‖ 
The process of health behavior change was similar across all of the behaviors: 
healthy eating, being active, handling stress, smoking cessation. The process was fluid. 
SMBG functioned to spark awareness, suggest adjustments, provide alignment, advise 
movement, and account for restraint. In these recently diagnosed participants, SMBG 
was central to sparking awareness of a need for change. In this way the numbers 
created a paradigm shift for participants. Next, as participants experienced making 
changes, the BG numbers played a role in their figuring out of the body‘s response to 
various contexts by suggesting adjustments and providing alignment.  
Routine 
Experience: “I Make My Numbers.” 
The participants experienced behavior change in the context of their routines. 
People who were able to control their blood glucose expressed a deep satisfaction from 
that accomplishment: 
Well, I am real pleased when I make my numbers. I am pleased with myself. It 
just makes me feel that I am staying within the guidelines that I am really 
concerned. And um that I am pleased that I can stay within the guidelines. 
The experience during routine was one of maintaining health behavior and restraining 
old habits. Participant narratives illustrated how routine could both facilitate and be a 
barrier to behavior change. Testing itself influenced routines. One person reported not 
eating during the 2 hours following BG testing when she was instructed to test 2 hours 
after eating. She said: 
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 Then it was nicer to do one at night especially the one after supper. Because 
first of all then you had to have 2 hours where you didn‘t eat, and my worse time 
of eating is after supper. [Right.] So I am more prone to think that that helps both 
ways. I‘m going to try that for next week. Because, then you have to have 2 
hours after you eat. And after 2 hours you don‘t want to eat anyway. Where it is 
those 2 hours that you continually want to munch.  
Another person had difficulty testing 2 hours after breakfast because she often delayed 
eating. ―I have to take my pills. I have to and I can take the test and stuff. But, you have 
to eat before, 2 hours before you test it.‖ The idea that you have to eat 2 hours before 
testing instead of viewing testing as an event following eating was one way that 
confusion about testing and its purpose in diabetes was evident. This participant 
described how she must be vigilant when eating out to prevent ―hidden sugars‖ from 
sabotaging her diabetes management efforts. But now an event she enjoyed has been 
transformed by the need to be careful, “I try and watch‖: 
 I get frustrated. Because you know, because, I like to go out with friends and eat 
and what not. And yet, they hide so many things in the foods that they serve you 
to help with the taste and everything to make it more enjoyable.  I just get 
frustrated because. I try and watch. But then you cannot watch everything when 
you are eating out whereas at home you can control it. Like sometimes the sliced 
carrots will have more sugar in them. And then sometimes, I always have to be 
very careful about asking for sugar-free iced tea because sometimes the 
waitresses make a mistake and you end up. But then I always mention to them 
so that I do get the right container. 
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The experience of transforming eating routines included having foods that were 
not part of a previous diet and limiting foods. Bread was one of the more challenging 
foods. This participant said that SMBG helped her to maintain her new routine of limiting 
bread. Evidence of the transformation is her statement about her previous bread eating, 
―I really haidn‘t [sic] missed it‘: 
So the numbers, the numbers will make you go on and do things that you need to 
do. And also and watch what you eat. I have been reading carbohydrates. It is a 
mess trying to shop. Well I really haidn‘t [sic], I was a big bread eater But, I really 
haidn‘t [sic] missed it and sometimes I go the whole day without eating any 
bread. I been eating some grapes and I eat some cantaloupe you know the 
portion size. Sometimes I will eat an apple sometimes a banana so ah, Well it 
just helps me if it is high I know I need to cut down on something. Now if it is low 
now, one time after lunch I checked it, it was down to 80 some so you know I 
knowed [sic] I needed to eat something. 
 She had not missed eating bread, but SMBG helps her to maintain her behavior. 
Another woman also transformed her bread eating behavior. She described how 
cornbread that was an everyday staple of her diet became ―something special‖: 
Well, I think and I still overeat. I am not going to lie and say sometimes I don‘t 
overeat. We try to make changes in the way we eat. We are country folks, we are 
country folks and we eat corn bread. I mean, you know, that was a staple on our 
table. Because it was fast number one and we work on the farm and have all this 
stuff. You run in at 8 o‘clock or 9 o‘clock and you say, ―what can I eat?‖ Oh, O.K. 
so you throw a cake of corn bread in the stove and we will have cornbread and 
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something, milk something. That was a no-no for me. That was one of the things 
the breads that really [elevates blood sugar].  So instead of having it every night, 
now we have it about twice a month. It is special. It is special to you then. So, we 
found out, I think, that because I think, your eating habits can do lots of things, 
and of course it‘s put a lot of weight on me. And I still need to lose a lot of weight. 
I am thankful for what I have lost.  
A man discussing how he adjusted to eating less bread:  
Well it was, the biggest thing was I [pause] I couldn‘t eat without bread, had to 
have bread. That was the hardest thing to put down. That was harder than the 
deserts and that kind of stuff. But I finally got to where that didn‘t bother me.  
A man adjusting his portion size said, ―I still eat some desserts from time to time but I 
don‘t eat much. I found out a couple bites is just as good as eating a big piece of pie.‖ A 
man describing self-education, reading labels to identify carbohydrates, and reading 
books: 
Well you know you just need to watch the carbs [sic], you know. I read labels. I 
go to the grocery store and read labels on all kinds of stuff. You just need to 
determine what you need to do. I am pretty settled now. It takes probably a year 
to get familiar with all the foods. I used to have a, you know I still have got it, a 
book that lists all the carbs [sic] and the servings and all that. I used to look at 
that quite a bit. 
The ease of cooking a meal was also important to other women. In this narrative 
a woman described the challenge of not having ingredients on hand, taking more effort 
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to shop, and the difficulty of planning meals. But now she is using some of the recipes 
that had been so difficult at first, evidence of her transformed routines, ―not ordinary”: 
 I was trying to use those recipes and it was driving me berserk. I was having to 
go and buy things that I didn‘t ordinarily have in the house. It was taking me 
forever to buy it, figure out what I was going to have, make it, and I was serving it 
to whoever was there, whether it was my husband--just my husband--or one of 
my kids. Some of them were great recipes. I still use some of them. 
Although routines related to eating were most common, activity routines were 
also discussed by participants. Weather and other time commitments such as company 
are common complications for maintaining activity routines: 
Yeah, and I walked more than I wrote down. I walked unless, one day I had two 
visitors and I didn‘t get to walk any that day. I try to walk every day. I can‘t walk 
sometimes. If the weather is right I can walk a half a mile at one time; but, a lot of 
time I do a quarter of a mile. But I do at least four a day if not more plus I walk 
down under the hill to the fish pond. I walk to my sister in laws. I try to get in all 
the walking I can. 
Activity was a new response to stress for this participant: 
I even went out last night for a little walk. Just on the top of the driveway because 
we live on a hill, because I was so frustrated that I had all this work to do and [my 
husband] couldn‘t do a thing to help me. I was ready to smash the dishes. So I 
just walked outside and said, ‗O.K. I can‘t walk up the hill because my back, my 
hip hurt too much.‘  So I just walked around the cars back and forth up and down 
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10 to 15 minutes. Looked at the flowers and said, ‗O.K. I am good. I can take this 
another day‘. 
The physical limitations she faced were common. Many people have conditions that 
make activity difficult. But now she uses activity to handle stress and this makes her 
able to keep going another day. 
Maintaining and Restraining 
In addition to the experience of restraining behaviors such as eating differently, 
the SMBG was important to help participants maintain the changes they had adopted. 
This participant viewed SMBG as maintenance work: 
People are um they have habits that are good and bad in life so it is very hard for 
some people to break their habits. It is like maintenance work. It is called 
preventive maintenance to maintain the flow, the right way; you know what I am 
saying? 
Habits made change difficult. ―I am trying to, like I say, we are creatures of habit so it is 
very hard to change basically routine. I think about it every day.‖ For some testing had 
become so integrated into their routine that it was no longer thought about. ―Well I 
usually always try to do it before I eat breakfast in the morning, and whenever I think 
about it. I don‘t think about it anymore.‖ 
Several people spoke of how routines influenced their success with behavior 
change. Some people were able to integrate changes into a routine and that improved 
their health behavior. Others were not able to change their routines to accommodate 
new health behaviors. Daily routine was important to testing behavior. People did not 
like varying testing from day to day. They considered what the future season might 
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mean to their ability to maintain healthy routines or adopt new routines. Many 
participants expressed hope but not confidence in their ability to adapt to a new routine. 
Forgetting was a barrier to testing: 
It doesn‘t really bother me to test now or anything. Now, I just have to remember 
now to do it. I get in routines and it is hard. Sometimes, I will sit down and maybe 
drink something, eat something, and ah ―I forgot to get the reading‖. And I have 
to wait a little bit and see where it is at. Sometimes I need to remind myself, ―You 
need to do this before you eat and after.‖  
Meaning 
“It is Not That Way Anymore” 
During routine, SMBG meant that behavior change had taken place and 
therefore, ‗It is not that way anymore‘: 
Well, yeah, I think, maybe I used to make a humongous pot of spaghetti so now I 
make a little pot of spaghetti [laughter]. You know, I think. I was cooking for three. 
It takes a little while to adjust that, that there are not three there anymore. I have 
a friend who grew up with 11 children and she said she helped her mother cook. 
So when she got married she made the same amounts as she did with all those 
children. She said she had all this food we have to throw away. I thought we had 
to make huge amounts. Hey, that is not the way it is any more. So we are cutting 
down even what we cook. Sometime you think I don‘t want this leftover, I will just 
eat it. I will just eat it. That is not good. So you are better not to have it. 
More evidence of adapting to a new pattern of living: 
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No, it is getting easier. It is not as frustrating now as it was at the beginning. [And 
what has made it easier?] Just knowing my choices in food, watching my 
carbohydrates and knowing what is in them, before I even eat them, the portions 
I eat, and the exercise I get. So that‘s really like I said motivates you to do things 
like that when you know what it could do. 
Success in one area of health behavior change rarely meant success in all areas. 
Here a participant who lost 50 pounds discussed her difficulty in maintaining an early 
evening meal pattern and her concern that the winter season will make her exercise and 
eating behavior more difficult: 
Well, I fess up that sometimes we still get into that pattern. I tried. That is one 
thing in our lifestyle that we have tried to change, is to go in and have something 
at 5 or 5:30 instead of 9 or 9:30 but sometimes we still get caught and that 
happens. We will be working on this again when it starts getting dark early and 
we have to go inside. I am a little bit, I don‘t know what the word is, concerned or 
I don‘t know I am worried about the winter months. You know you are inside and 
sometimes it seems like you think comfort food or you think, ―Hey it is in here and 
I just want something to eat.‖ I guess we will just have to see how I manage that 
during the winter. Hopefully, I can keep everything at least where I am. 
Despite the uneven integration of health behavior, a new routine emerged for 
most participants. It is this new pattern born out of the experience, appraisal, and 
rational intuiting that is the strongest evidence that SMBG contributed to the 
personal knowledge and experience of living with T2DM. 
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Function 
Congratulates 
“I am doing something about it”. SMBG provided people with a perception that 
they were doing something about their diabetes. All of the participants in the two highest 
HbA1c groupings (HbA1c ≥ 6.5%) told stories of people who were not taking care of 
their diabetes: 
It just blows my mind today how people take it so nonchalantly. I was, I visited, I 
probably shouldn‘t say where, cause… but anyhow. You see people that are 
really grossly overweight and I was just talking to this fella [sic] and he said that 
morning his bloods sugar was 400 or something. I am thinking. ―There is 
something that you can do about that‖ but it didn‘t seem like, He was just taking 
his medicine. I don‘t understand that. 
SMBG helped participants feel secure and demonstrated their efficacy in contrast to the 
stories they told of others who either did not test their BG or were not demonstrating 
healthy behaviors. Here a woman explains how SMBG helped her prove to herself that 
she was actively doing something about her diabetes and knowing where her BG 
readings were: 
But I guess it made me realize that this is something I needed to do to improve, 
to get more healthy. And Just sticking your finger even though this stick is 
nothing like the one in the hospital, like I said. It makes you realize that, what I 
don‘t know, I hadn‘t thought about it. Well, that is a way of proving where you are 
one way or the other. And what you are doing about it. 
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SMBG motivated continued health behavior by advising movement or accounting for 
restraint as satisfaction in the numbers themselves maintained and restrained behavior. 
The behavior of SMBG was satisfying. It assured participants that they weren‘t like 
those ―others‖ who were not concerned or not testing. Participants expressed 
satisfaction in making their numbers.   
Comforts 
“Knowing where I am at”. SMBG comforted participants providing them with a 
feeling of security. Experience with testing resulted in anticipated readings: 
But I have got to where I kind of know where I am at. According to what I had to 
eat I will check it a lot of times before I eat to see where it is. Well it makes you 
feel [pause] If you keep your blood sugar where it‘s supposed to be you feel a lot 
better, you really do I mean, I get really concerned when it gets high. If it gets 
around 150 I will back up and do something to get it down. 
Or helped participants who tested in the morning to know where they were at in order to 
plan their day. ―Well, I like to do it in the morning before breakfast so I know where I am 
starting out and that kind of gives me an idea of what I can eat that day.‖ This helped 
participants feel secure. This man described this function of testing as keep him ―in 
contact‖: 
Well the numbers that they gave me to check with was 120 in the morning, 180 
two hours after lunch and 140 in the evening 2 hours after snack about ten, 
between ten or eleven. And I pretty much could stay within those points. I like 
testing twice a day. It would keep me more in contact with how I was doing. 
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The congratulating and comforting function of SMBG motivated the ―figuring it 
out‖ of behavior change and the ongoing maintenance work of routine by rewarding 
those who could ―make their numbers‖ (Table 5). 
Table 5  
SMBG A Motivator During Routine 
 
Behavior Process Narrative Summary 
Motivating action ―It (SMBG) gets me out a walking. Sometimes 
my legs, my hips, my back don‘t feel like it but I 
push myself to do it as much as I can and 
every day that I can.‖ 
Spark Plug  
Motivating restraint ―It (SMBG) holds me accountable for one 
thing. If I didn‘t have to do that, If I didn‘t feel 
bad. I might not. I would be tempted to cheat 
and to not do.‖ 
Guard Rail 
This male participant provided insight into how SMBG, as a visual reminder, 
functioned to motivate behavior by keeping diabetes out in the open when other 
physical symptoms of disease were not evident: 
A little bit, out of sight, out of mind, I think not. People generally need a little bit of 
a reminder. Because if you don‘t feel bad and you‘re not doing it [SMBG] then 
you are more likely to mess up I believe.  
Finally, participants discussed the importance of routine as either a barrier to or a 
facilitator of behavior change. Despite the success experienced by many of these 
participants, not one described his or her efforts at behavior change as permanent. 
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Most discussed their day-to-day struggle to continue with changes or reported their 
likelihood of initiating or maintaining a change as ―midways.‖ Consistent with other 
findings (e.g. Aujoulet et al, 2007; Jones et al., 2000; Rayman & Ellison, 2004; Tilden et 
al., 2005), this honest assessment illustrated the fluid and challenging experience of 
maintaining health behavior change for people with T2DM. As behavior change became 
routine, SMBG functioned to maintain and restrain routines (Table 6). 
Table 6  
SMBG Maintaining and Restraining Routines 
 
Maintaining 
(Alignment) 
Restraining 
(Brake) 
―Well, I am real pleased when I make my 
numbers. I am pleased with myself. It just 
makes me feel that I am staying within the 
guidelines that I am really concerned. And 
um that I am pleased that I can stay within 
the guidelines.‖ 
 
―Then it was nicer to do one at night 
especially the one after supper. Because 
first of all then you had to have 2 hours 
where you didn‘t eat, and my worse time of 
eating is after supper. So I am more prone 
to think that that helps both ways. I‘m 
going to try that for next week. Because, 
then you have to have 2 hours after you 
eat. And after 2 hours you don‘t want to 
eat anyway. Where it is those 2 hours that 
you continually want to munch.‖  
 
Analysis of the Logbook 
Seven of the 11 participants brought in blood glucose logbooks. Six of the seven 
actually had written logs and one participant brought his meter with its electronic 
memory. Two male and two female participants did not bring in logbooks. Three of the 
four participants not bringing logbooks were in the lowest HbA1c group. The fourth 
participant who did not bring a logbook was in the highest HbA1c group.  
Three people used the glucometer manufacturer‘s logbook to keep records. 
Three women created their own logs. These self-made logbooks were very detailed and 
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included additional health information such as a food diary with carbohydrate counts, 
blood pressure readings, weight, minutes of activity, and medication records. Even 
those who used the manufacturer‘s logbooks included additional information such as 
weight or minutes of activity. Sometimes when people obtained unexpected readings, 
they would record possible explanations in the logbooks. In addition to providing 
examples of figuring out diabetes with applied numeracy, the logbooks demonstrated 
interpretive numeracy processes with symbols such as question marks, exclamation 
points, smiling and frowning faces. One participant drew a frowning face next to an 
elevated reading. When asked about this notation she said she thought I might not be 
happy to see that number but then modified her story to say that she was not happy 
with it either. Some people were very precise in their documentation for example, 2:38 
PM. Others, used 5-minute increments and still others just used the designations before 
or after. These participants had saved all their logbooks. In addition to her logbook, one 
participant brought in books and other materials she was using to help her understand 
diabetes. Although participants with logbooks reported that they were very useful, even 
those with the most detailed logbooks had periods in which they did not use the logs. 
Logbooks seemed to support both the experience of ―figuring it out‖ and ―maintaining 
and restraining‖ health behavior. 
The study findings were organized around the three time periods of SMBG: 
Diagnosis, Behavior change, and Routine. Within each time period the experience of 
living with T2DM was summarized and the meanings and functions of SMBG during the 
time period were represented. Some elements of the richness of this data were 
necessarily excluded. You, the reader, cannot hear the intonation of each participant 
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nor see the subtle mannerisms that communicated along with words. I have tried to be 
faithful to both the spoken and unspoken representations of the participants. When 
participants were presented with the study findings, they responded by spontaneously 
pointing to the diagram (Figure 1) and saying, ―This is where I am at.‖ This response 
confirmed the ability of participants to recognize their experience in this representation. 
This process of verification strengthened the credibility of the study findings. 
Participants confirmed that Figure 1 represented some aspects of their SMBG 
experience. 
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CHAPTER 5 
DISCUSSION 
The themes derived from the process of narrative and logbook analysis were 
used to represent the participants‘ stated meaning and function of SMBG during the 2 
years following a diagnosis of diabetes. Figure 1 illustrates three time periods of this 
lived experience of T2DM. Metaphors reflect the participants‘ appraisals of future and 
past performance and are integrated with Schapira et al.‘s (2008) hierarchy of numeracy 
framework. The outcome of personal knowledge is the recognition of a new pattern 
(Sweeny, 1994). This outcome was evident in the participant expressions ―but now‖ and 
―It is not like that anymore.‖ This chapter places the study‘s findings in relation to 
research findings for three theoretical processes of personal knowledge: experience, 
appraisal, rational intuiting. Procedures including memoing and discussion of findings 
with content experts and participants strengthened the study findings; however, an 
important measure of rigor for studies using methods of interpretive description is the 
application and adoption of findings to clinical practice (Thorne et al., 2004). Therefore 
this chapter concludes with suggestions for nursing practice, nursing education, and 
future research surrounding the use of SMBG in T2DM.  
Related Research Findings 
Experience 
 Researchers have identified three processes of integrating self-identity and 
illness experience: integrating, separating, and vacillating. (e.g. Aujoulet et al., 2007; 
Jones et al., 2000; Rayman & Ellison, 2004; Tilden et al., 2005) In this study all three 
process were evident as people experienced a desire for control alongside an  
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Figure 1 Self-Monitoring Blood Glucose Function 
ROUTINE 
―It is not that 
way anymore.‖ 
Interpretive 
BEHAVIOR  
CHANGE 
―I can control it. It 
doesn‘t have to 
control me.‖ 
Applied 
 
DIAGNOSIS  
―I look to the Lord 
for strength.‖ 
Primary 
―The 
numbers 
say I have 
diabetes.‖ 
Comforts 
―I am some 
kind of OK.‖ 
 
Confirms 
―Now there are no 
question marks.‖ 
―The numbers 
make me do.‖ 
(Extrinsic) 
―I don‘t want to 
end up like my 
…‖ 
(Intrinsic) 
Clarifying or 
Confusing 
 
―Figuring it out.‖ 
Marker 
and/or 
Motivator 
Contemplating 
Behavior 
Change 
―I can control it. 
It doesn‘t have 
to control me.‖ 
Maintaining/ 
Restraining 
―I make my 
numbers.‖ 
Considers 
―I just don‘t know 
why it does that.‖ 
Comforts 
―I like to know 
where I am.‖ 
 
Congratulator 
Evaluator 
―I am doing 
something about it.‖ 
 
 
 
 
 
―Knowing Where I Am At‖ 
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 acknowledgement of contingencies that prevented total adoption of management 
ideals. For example having company (a contingency) might prevent a participant from 
maintaining a walking goal (management ideal) on some days. Participant narratives of 
the experience of SMBG and T2DM generally described three time periods: Diagnosis, 
Behavior change, and Routine. These time periods usually but not necessarily flow from 
one into the next. For example one participant who had not accepted his diagnosis 
made behavior changes. A more common expression of vacillation came during 
Behavior change and Routine. Participants who predominantly experienced Routine 
would at times reconsider Behavior change. The findings confirmed a fluid process of 
adaptation though out the T2DM illness experience. 
Although not focused on SMBG, a recent qualitative study examined the 
experience of diabetes nurse check-ups as narrated by people with T2DM in Sweden 
(Edwall, Hellström, Öhrn, & Danielson, 2008). They interpreted these narratives as 
nurse visits influencing patients‘ experience in an interlinked chain: being confirmed, 
being guided within the disease process, becoming confident and independent, and 
being relieved. The current study confirmed a similar illness experience. For example in 
this study participants used SMBG to confirm their diagnosis. They used SMBG to guide 
their behavior change and said that SMBG meant that they were competent. They also 
expressed relief that they were ―some kind of O.K.‖. In this way many of same 
processes that were attributed to the nurse visit (Öhrn et al.) were attributed to SMBG in 
this study. The influence of the nurse-patient relationship and the use of SMBG may be 
difficult for participants to separate and likely both have influenced the T2DM illness 
experience. 
113 
 
 Clar et al. (2010) reviewed the evidence base surrounding the value of SMBG 
and reported the random control trials (RCTs) included in their review did not 
acknowledge that SMBG is not necessarily an intervention without education, feedback, 
and behavior adjustment. They defined significant improvement in metabolic control as 
a change in HbA1c >0.5%. Their review concluded that the RCTs did not analyze the 
context (patient characteristics and situations) in which SMBG is most helpful. In this 
study use of SMBG was clearly defined in a self-regulating model and focused on the 
participant‘s life-context and experience of diabetes self-management through 
discovery. This study defined the context of the function and meaning of SMBG during 
Diagnosis, Behavior change, and Routine. In addition 8 of the 10 participants who 
followed up for care significantly improved (>0.5%) their metabolic control as defined by 
Clar et al. Both of the two participants with nonsignificant changes were in the lowest 
HbA1c group (HbA1c ≤6.4%) meeting the American Association of Clinical 
Endocrinologist target for metabolic control, HbA1c < 6.5% (Jellinger et al., 2006). One 
had a Hba1c improvement of 0.4% and the other had a 0.2% improvement. Although a 
small cohort, the participants in this study demonstrated significant metabolic 
improvement with this model of self-regulating using SMBG to educate, provide 
feedback, and support behavior change. 
Appraisal 
 Researchers concluded in their qualitative study of narratives from 119 people 
living with diabetes that central to participant moral discourse were expressions of 
control (Broom & Whittaker, 2004). In addition they identified chaos narratives as 
primary to their participants‘ narrative appraisal. In this study chaos narratives were 
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evident in some participants‘ narratives. However, restitution narratives were most 
common as participants coherently stated a problem solving experience with a 
beginning, middle, and end. These restitution narratives illustrated participants‘ control 
over T2DM while those with the chaos narratives demonstrated their absence of a 
coherent story and contained emotional overtones of events being out of control.  
Researchers (Schlenk & Boehm, 1998) used contingency contracts to strengthen 
the self-efficacy beliefs of participants. Contingency contracts make an individual aware 
of potential barriers to behavior performance while planning to overcome these 
performance barriers. The current study framed self-efficacy as an appraisal of future 
performance. Frank (1995) used the term contingent as the end point along the control 
continuum. In this study the expression, ―It doesn‘t control me. I can control it‖, was a 
common appraisal of self-efficacy among participants. This expression would be found 
on the predictable end of Frank‘s control spectrum while, ―I just don‘t know why it does 
what it does‖ reflected feelings of being out of control and toward the contingent end of 
the spectrum. In this study evidence of both appraisal of past experience as being out of 
control and appraisal of future experience with expectations of control were reflected in 
participant appraisal of their commitment to behavior change as ―midways.‖  This finding 
is consistent with one of Frank‘s body problems, control. It also demonstrates 
participant acknowledgement that contingent experiences prevent predictable control. 
In a review of 26 RCT Clar et al. (2010) observed that both patients and 
providers did not use SMBG to recognize the impact of changes in dietary and exercise 
behavior. In contrast participants in the current study were encouraged to use SMBG to 
appraise their BG response to behavior changes including diet, exercise, and stress 
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management. It is likely that this self-regulating experience contributed to the finding 
that participants expressed both being in and out of control during the process of 
behavior change. 
Rational Intuiting 
 Finally, rational intuiting is bounded in this study by numeracy literature and 
communication of health information (e.g. Ancker & Kaufman, 2007). Since this study 
was developed, the numeracy literature has grown exponentially. Among these newer 
publications, Schapira et al (2008) conceptualized three processes occurring in health 
numeracy as a hierarchical triangle of primary, applied, and interpretive processes. This 
model appears to have a good fit with the numeracy experiences of participants in this 
study. Rational intuiting was expressed as, ―the numbers say I have diabetes‖, ―figuring 
it out‖, ―the numbers make me do‖, ―and I don‘t want to end up like my…‖, and I am 
happy when ―I make my numbers.‖ All three numeracy processes were evident in the 
study findings. Applied numeracy processes were found in the logbooks as participants 
recorded minutes of exercise (counting). Applied numeracy processes in logbooks were 
evident when participants aligned their consumption of carbohydrates to the number of 
carbohydrate grams prescribed for each meal. Participants demonstrated the third 
numeracy process, interpretive numeracy, when they told cautionary tales of others with 
diabetes and concluded that they ―didn‘t want to end up like that.‖ In this way this 
study‘s findings confirmed Schapira e al.‘s conceptualization of numeracy. 
Prior to this completing this study I would have agreed with the conclusion, 
―…there is no point in collecting data on blood glucose levels if nothing is done with the 
data‖ (Clar et al.,  2010, p. 45). The problem with this statement is that health care 
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providers have difficulty observing internal self-regulatory processes and conclude that 
―nothing‖ is being done with the data. The participants in this study reported that even 
when there was no external evidence of behavior change interpretive numeracy 
processes were at work helping participants maintain behavior change or restrain old 
habits. This finding is also congruent with the conceptualization of personal knowledge 
as knowing more than can be told (Polanyi, 1966). 
A Framework for SMBG Function in T2DM 
 The three time periods of the illness experience were experienced as, Diagnosis, 
when ―I look to the Lord for strength‖; Behavior change, when ―I can control it. It doesn‘t 
have to control me‖; and, Routine when ―It is not like that anymore.‖ Within these time 
periods the metaphors derived for the appraisal of T2DM included the numeracy 
processes ―the numbers say I have it‖, ―figuring it out‖, ―the numbers make me do‖, 
―numbers mean I won‘t end up like  . . .‖, and I like it when ―I make my numbers.‖  
Recognizing a new pattern as a result of experience, appraisal and rational intuiting is 
evidence of personal knowledge (Sweeney, 1994). All of the participants, even the one 
participant who had not yet accepted his diagnosis, provided narrative evidence of 
adopting a new pattern. SMBG contributed to pattern identification during all three time 
periods. 
Diagnosis 
When newly diagnosed with any illness people commonly question why do I have 
this disease (Kleinman, 1988)?  In this way people search to find explanatory models for 
their medical conditions. Participants in this study made appraisals of their risk for DM 
by considering if they had family with DM. If they did not, they expressed more difficulty 
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answering the question, why? Participants overwhelmingly stated their belief that 
diabetes was genetic and one participant put it bluntly that because she inherited it, 
diabetes was not her fault. In the absence of symptoms of disease, both participants 
with and those without diabetic family members used SMBG to answer the question, do 
I really have diabetes? All used SMBG to confirm that they had diabetes during the 
diagnostic time period. In this way SMBG answered participants in this common illness 
experience of asking why? and really? with the appraisal, ―the numbers say I have 
diabetes.‖ 
Participants described the experience of being diagnosed with T2DM as a 
―shock.‖ Although those in the lowest HbA1c group (HbA1c ≤6.4%) experienced less 
belief in their diagnosis and those in the higher two HbA1c groups (HbA1c 6.5%-6.9%, 
HbA1c ≥7.0%) experienced diagnosis as more of a ―wake-up call‖, they all used primary 
numeric processes to identify if their BG readings were on target. Numbers were used 
following diagnosis to confirm the existence of T2DM. 
 Once participants confirmed their diagnosis they were asked to use SMBG to 
identify times that BG elevated. This was uncomfortable for participants who wanted 
reassurance that they were alright. Researchers (Simon et al., 2008) also observed this 
experience of testing to obtain a normal reading in the Diabetes Glycaemic Education 
and Monitoring study (DiGEM, 2008). Two of 40 participants in the qualitative arm of the 
study reported timing their testing to achieve their best readings (Simon et al., 2008). 
This discomfort with abnormal readings is consistent with the ideal of the disciplined 
body that seeks control and predictability (Frank, 1995). Once participants began testing 
at various times, they experienced clarification or confusion with their readings in 
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contrast to the predictability they sought. They began to consider their life-context and 
the effect their behavior had on blood glucose readings. Participants in all three HbA1c 
groups reported moments of clarity when they ―figured out‖ what was making their blood 
sugar go up or how to make it go down. They began applying numeracy processes to 
make health behavior decisions. For example, those in the two lowest HbA1c groups 
(HbA1c < 7.0%) found elevated fasting readings puzzling. While those in the highest 
HbA1c (HbA1c ≥ 7.0%) group did not find fasting readings difficult to understand but 
described many other testing circumstances as a mystery to them. Thus, the appraisal 
of ―figuring it out‖ was expressed by all three groups, but in different contexts.  
Behavior Change 
Once their problem was out in the open, participants began considering active 
behavior change (Table 7) dependent on what they had learned through testing. During 
Behavior change the numbers functioned as an extrinsic motivator and an intrinsic 
motivator for action. Participants appraised this function by saying that the ―numbers 
make me do.‖ Evaluating a reading as at or not at target made some people maintain 
health behavior. For example people initiated activity or restrained health behavior such 
as eating less.  This is in contrast to Peel, Douglas, and Lawton‘s (2007) interview of 18 
patients over a 4-year period. Researchers concluded that there was little evidence that 
participants in the UK were using SMBG to effect and maintain behavior change (Peel 
et al., 2007). This difference is likely due to the exposure participants in this 
implementation of a model of primary care in which SMBG was introduced in a 
personalized, educational, and problem-solving approach.  
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Table 7  
SMBG for Health Behavior Change  
 
Health Behavior Narrative Summary 
 
Marker and Motivator 
 
―It [SMBG] gives you a tracking device, a daily 
tracking device.  So that you can tell how to 
adjust your eating, or your resting, or you know 
going out for a walk or whatever [it] takes you to 
reduce your stress to being more level the next 
day.‖ 
 
 
Global 
Positioning 
System  
Evaluator and 
Congratulator 
―It [SMBG] makes you aware that eating 
healthfully is important and the blood sugar 
testing gives me a way to check if I am doing it.‖ 
Traffic 
Light 
 
Maintaining and 
Restraining 
―Oh gosh, helps me manage it, well, I know I 
have to do a little more exercise if my numbers 
are higher. I know I have to be a little more 
careful when I go out to eat. So it [SMBG] keeps 
me in line for me personally.‖ 
Alignment 
and 
Brake 
 
In addition participants made appraisals of others as evidenced by their stories of 
family members or friends who had suffered with diabetes or who had experienced 
diabetes related illnesses and deaths. These narratives were consistent with Frank‘s 
(1995) characterization of other-relatedness. The dyadic relationship could be an 
emotional base for constructing self-management (Furler et al., 2008). For some 
participants the numbers brought forth memories of these negative illness-related 
120 
 
consequences and functioned as intrinsic motivators, ―I don‘t want to end up like…‖ The 
BG readings also functioned as a marker to participants that they were doing what 
needed to be done to control their diabetes unlike those ―others‖ who were out of control 
or experiencing an unwelcomed illness contingency.  
Finally, the numbers congratulated those who changed their behavior and 
became a source of self-satisfaction, ―I am real happy when, I make my numbers‖.  The 
cycle of change and congratulating and evaluating was ongoing and fluid. Evidence 
from logbooks demonstrated that people applied numeracy processes such as counting 
carbohydrates, keeping track of minutes of exercise, and actively using SMBG 
information to evaluate their body‘s response to health behavior. People were not 
confident that they could maintain behavior change. Even those who demonstrated 
successful weight loss or dietary change reported that they were only ―midways‖ certain 
that they could continue.  
Routine 
The third time period for those living with diabetes was the experience of 
Routine. The desire to ―know where I am at‖ was expressed by participants when 
SMBG became routine. This finding is consistent with Peel et al. (2007) who identified 
reassurance and habit as reasons for continuing with SMBG. In addition to SMBG 
dietary changes such as no longer eating bread at meals were most often reported as 
now routine. Activity changes were reported such as walking after evening meals. 
Participants noted this in their narrative appraisals with phrases such as ―But now I‖ and 
―It is not like that anymore.‖ Participants provided narrative evidence of former behavior 
and contrasted it with current behavior. Participants employed interpretive numeracy in 
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their decisions to continue with health behaviors and made SMBG routine. They 
evaluated their perceptions of risk and benefit as they appraised their own likelihood of 
maintaining their health.  Once a SMBG routine was established, SMBG functioned to 
comfort participants. To them SMBG meant that they were in control. They were no 
longer using SMBG to change behavior but to maintain their new health behavior or 
restrain their old habits. All participants, even the one participant who did not fully 
accept his diagnosis, considered various new healthful patterns. Evidence of personal 
knowledge is the recognition of a new pattern (Sweeney, 1994). The new pattern is an 
outcome that likely influences HbA1c. Although useful for periodic assessment of 
metabolic status, the HbA1c does not provide the day-to-day evaluation and problem 
solving potential of SMBG. Diabetes health professionals can listen for the ―But now‖ 
that indicates health behavior change and provide a strong emotional base for people 
striving to continue in maintaining health routines. They can guide patients‘ use of 
SMBG to establish health behaviors that lead to improved metabolic control. 
Practice Implications 
 Align SMBG goals. One goal of the self-regulating SMBG guideline for primary 
care practice was to identify when blood glucose was most problematic (ie. postprandial 
BG). Participants did not like answering this question. Their goal in testing was to 
provide comfort during a time when they felt extremely threatened by a diagnosis they 
associated with death, loss of limb, and suffering. Despite this discomfort, most 
participants eventually became confident enough to begin ―looking for trouble.‖ One 
participant clearly stated how she was aware that she transitioned from testing to 
comfort herself to testing to guide health behavior change. It is important to consider 
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how numeracy information is presented to patients (Ancker & Kaufman, 2007). 
Acknowledging the common desire to test for comfort may be the first step towards 
open discussion of the participant‘s readiness to begin testing for health behavior 
change instead of testing for comfort. Health professionals should shape the way they 
introduce problem solving recognizing, that testing in order to identify problem blood 
glucose readings is difficult for patients. Researchers concluded that patients did not 
perceive that practitioners believed SMBG to be important and that patients did not 
often act on their numbers (Peel et al., 2007). In addition patients expected practitioners 
to use SMBG information to change diabetes therapy, and practitioners expected 
patients to use the SMBG information to change their health behavior (Peel et al., 
2007). Awareness of these differences in patient and provider perceptions is critical to 
shared understandings that have the potential to improve health communication. 
Negotiating clearly communicated goals for SMBG is likely to strengthen the efficacy of 
SMBG for metabolic control. 
 When patients see they believe. Participants expressed satisfaction with the 
factual and exploring approach used to teach them about their T2DM. Although those 
with the lowest HbA1c (HbA1c ≤ 6.4%) had the most difficulty believing their diagnosis, 
they said that seeing the numbers helped confirm their DM diagnosis. Also, after weeks 
of monitoring her BG response to eating and exercise one woman began taking 
Metformin to treat T2DM. Seeing the response her BG had to the medication helped her 
accept medical treatment for diabetes. Perceived treatment efficacy is particularly 
problematic for people with T2DM (Polonsky & Skinner, 2010).  If she had not started 
with SMBG to learn about her problem, she may not have accepted or continued with 
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medical treatment. Polonsky and Skinner (2010) recommend ―home experiments‖ 
similar to those used in this study to strengthen acceptance of diabetes related 
treatments. Allowing a period of time for participants to test their blood sugar at different 
times and under different situations appeared to improve the acceptance of diabetes 
diagnosis and treatment. In this way the illness experience of integrating the AADE-7™ 
health behavior, taking medication, is supported with SMBG. 
Transform the chaos narrative. Congruent with my clinical experience and 
Frank‘s (1995) conceptualization of illness narratives, most participants presented either 
chaos narratives or restitution narratives surrounding their life or T2DM experiences. To 
a lesser extent elements of a quest narrative were also evident in the transcripts. In my 
clinical experience the chaos narratives are the most difficult to hear. In the chaos 
narrative participants do not present a coherent story (Frank, 1995). They present 
themselves with a list of experiences jumping from topic to topic seemingly without 
insight and without a discernable beginning, middle, and end (Frank, 1995). This is 
different from the person who is moving in and out of behavior change or who otherwise 
might be struggling with an aspect of self-management. People who present with a 
chaos narrative do not often recognize a new pattern, although they may be actively 
making behavior changes. They appear to experience much of life as haphazard. They 
rarely interpret changes they have made as a new pattern or communicate to others 
that this change has occurred. Along with being a witness to the chaos narrative, one 
possible response to the chaos narrative is to restate the story that the participants 
themselves cannot verbalize with a beginning, middle, and end. If a person presents to 
a health care provider, at least one ―story‖ (and often many more) exists that a provider 
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can offer to a patient. The action of keeping an appointment should be viewed as a 
positive health behavior. ―You found out you have diabetes, you learned how to test 
your blood sugar and you came today because you want to pay attention to your 
health.‖ One of the two participants who presented with a chaos narrative made a 
number of dietary changes. It seemed important to support these changes by stating the 
―But now‖ for the participants that they were unable to state for themselves. For 
example, ―You used to eat donuts all the time; but now, you haven‘t eaten a donut in 
months.‖ Participants with chaos narratives are unable to organize their experience into 
a whole. Therefore, they are the least likely to find patterns in their blood glucose 
readings. It is especially helpful to interpret these BG readings for them in ways that 
maintain their integrity and promote self-regulating efficacy. 
At times less education is more productive. Once participants began testing ―to 
figure out‖ diabetes, they began to ask difficult questions. Despite being told about the 
liver‘s role in glucose regulation, most of the participants with HbA1c < 7.0% were still 
puzzled by early morning hyperglycemia. It is possible that understanding the hepatic 
contribution to hyperglycemia is counterproductive for health behavior change early in 
the T2DM experience. Ancker and Kaufman (2007) have reported the importance of 
framing to improve comprehension of health information. Participants in this study were 
told that the liver was like a snack bar that was open all night to feed them. Despite this 
simplistic frame, hepatic contribution to hyperglycemia was not an accepted explanatory 
model for those newly diagnosed with T2DM. Participants did not accept that anything 
except food or stress would elevate their BG. It is possible that the confusion fasting 
hyperglycemia creates motivates behavior change. Therefore, teaching about the 
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hepatic contribution to hyperglycemia may be less important during the period of early 
learning following a diagnosis of T2DM. In contrast, participants were pleased with the 
response that their bodies had to exercise. They were motivated for activity to ―make 
their numbers.‖  
Patients value routine testing. As the novelty of SMBG wore off people began to 
be able to predict how their body would respond to various foods or activities. At this 
point the self-regulating SMBG guideline for primary care practice attempted to move 
people to testing twice a day 3 days a week. However, participants did not like to test 
less than once a day even though some participants stated that one test alone did not 
provide enough information. They did not want to save one day‘s test strip to test twice 
on 3 days. They wanted to test as a marker (sign) so that diabetes didn‘t become ―out of 
sight out of mind‖ but they no longer had strong emotional reactions to elevated blood 
sugar readings. If readings were elevated participants considered eating a little less or 
differently and exercising more. They stated that they could ―make their numbers‖ but 
they were less confident that they would. None of the participants wanted to test less 
often than daily if they could afford the test strips. The routine of testing helped keep 
them in line with their own goals. Participants criticized others with T2DM who were not 
testing because testing was perceived as taking control of diabetes. However, people 
with longstanding diabetes may have different processes of evaluating their health 
behavior. Reinitiating testing to solve a particular problem may meet the needs of adult 
learners who are actively questioning the efficacy of diabetes interventions. People with 
longstanding T2DM may not benefit from testing the way that those with a more recent 
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diagnosis benefit.  Participants in this study stated that daily testing was essential to 
―know where they were at.‖  
Listen to the journey. Using SMBG was framed as an exploration of the body‘s 
response to eating, activity, medication, and stress. Participants‘ findings were 
discussed during a medical visit in the primary care office. Participants stated that the 
personal nature of their health care was important to them. One participant described it 
as ―It is the listening that I want.‖ Another participant found it helpful that information 
was presented to her factually and then she was asked to see what she could do. She 
described this as ―not patronizing.‖  
What I have really liked about your approach is that you don‘t patronize; but, you 
give people the facts. You tell them this is possible. And you kind of, you leave it 
up to them to make the changes. It is a form of encouragement without feeling 
like I am being treated like a baby. The last time I came here, you said, ―if you 
keep losing weight…another eight pounds and you will be in the normal range.‖ I 
felt like I can do that. ―Give yourself a year‖. I didn‘t feel like I had to do that within 
the week. It is not that you say, ―You can do this‖. But you give the fact. I felt like 
it was up to me to make those changes. That to me was very encouraging. I felt, 
―Yeah, I can do that.‖  
The belief ―I can do that‖ reflects the need for control that is common to illness 
experiences (Kleinman, 1988). The desire to have diabetes care personalized is 
consistent with Furler et al. (2008) who reported that it is the relationship more than the 
educational classes that are important for behavior change. One participant was critical 
of a former health care provider who pointed him to the internet for diabetes related 
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information. Participants in this study expressed a desire to have their T2DM 
management personalized to their lives. Nurses can learn to help those early in the 
disease process to appraise T2DM through SMBG. 
“Good” and other moral judgments. If diabetes health professionals listen to 
people with T2DM, they can hear deeper and often unstated functions and meanings of 
SMBG. The moral implications of SMBG were explored by Broom and Whittaker (2004). 
Their study of Australians with diabetes found that diabetes was not as stigmatized as it 
was 10-25 years ago. Broom and Whitaker reported that a common explanatory model 
for a diabetes diagnosis among their Australian participants was ―lifestyle‖ unlike this 
study‘s participants who focused on the genetic etiology of diabetes with a nod to their 
own personal responsibility.  
An example of moral overtones in participant description of BG readings is their 
assessment of readings as ―good‖ or ―unacceptable.‖ In practice patients often respond 
with one word to the question of, ―what are your BG readings?‖ That word is ―good.‖ In 
order to avoid the personal or professional moral judgment of BG readings, framing of 
this discussion requires more planning. For example asking ―Are your BG readings first 
thing in the morning between 80 and 120?‖ avoids a moral response. This question 
provides context (morning) specificity (between…) and personalization (your). It avoids 
either personal or professional judgment and educates by defining the target range.  
Moral judgments are best made by participants themselves as they clarify their 
own values. At the conclusion of an interview, one participant told a story about a man 
and wife who died and went to heaven. The moral of the story was that healthy behavior 
delays your good life in heaven. This fable‘s conclusion is in contrast to today‘s focus on 
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healthism. Healthism interprets failed health behavior as a personal moral failure 
(Crawford, 1980). Later this participant did not return for his follow-up appointment. I do 
not think that he knew at that moment that he was not going to follow-up. However, 
perhaps as he listened to his own story he discovered what he thought about his health 
behavior. The role of listening to patients helps them to clarify their own goals and 
expectations and gives providers insight to health processes.  
Peel et al. (2007) concluded that women more than men use readings as a proxy 
for good or bad behavior. Patients who respond to the question ―what are your blood 
glucose readings‖ with ―O.K.‖ or ―good‖ are measuring their behavior. Their response 
may reflect the need that people with T2DM have to feel reassured in relation to their 
health status. This need was also represented in logbooks with pictures of smiley faces 
next to readings on target. Likewise, self-judgments or comments such as ―lazy‖ were 
found in the logbooks of women. The nurse can have an important role in supporting 
this concern while creating a safe environment for beginning health behavior change. 
Asking patients if they are ready to find out how their body responds in different 
settings, ―Now that we know your readings are on target before lunch, I wonder if you 
would consider checking 2 hours after a meal?‖ Prior to this study I did not appreciate 
the need for reassurance and the importance that patients placed on achieving a target 
reading. Disregarding or minimizing when patients achieve a target blood glucose 
reading threatens patients need for control (Polonsky & Skinner, 2010). Achieving a 
target can be viewed as providing agency for future testing when the readings may not 
be as satisfying. Limiting testing to achieve a good reading has been reported in other 
studies (Peel et al., 2007; Simon et al., 2008). Participants‘ need for control prevents 
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them from testing at different times, risking an off target reading and considering health 
behavior change.  
“But now, it is not that way anymore”. Applying numeracy skills by presenting 
SMBG as a self-regulating intervention has potential for supporting behavior change. 
Evidence of a new pattern of behavior and personal knowledge of diabetes in the 
narratives was found in the expression, ―but now‖ and ―It is not that way anymore.‖ 
Letting go is the other side of control (Kleinman, 1988). Recognizing a new pattern is 
the outcome of SMBG for people with T2DM. This outcome is challenging to measure 
because even those who perform healthy eating and exercise behaviors admit that they 
are only ―midways‖ confident that they can continue in their behavior. Evidence of 
SMBG‘s influence on behavior is inconclusive (French et al., 2008). However even 
studies that are unable to conclude that SMBG changes health behavior acknowledge 
that SMBG has the potential to contribute to metabolic control by supporting behavior 
change (Clar et al., 2010). 
It is difficult to create a credible mathematical model that captures the health 
impact of walking after an evening meal in response to elevated BG readings. However, 
the participants who used SMBG made statements indicating that SMBG provided a 
measure of protection for their health. When health practitioners hear a form of the 
expression, ―But now‖, it is evidence that active behavior change has occurred. Efforts 
to support and maintain this change should be considered. The application of numeracy 
skills to ―figure out diabetes‖ is clearly important and the most evident role of SMBG to 
most practitioners (Clar et al. 2010). However, from my perspective, the time these 
participants applied numeracy to behavior change seemed brief. Participants spent 
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most of their time in one of two places; either confirming their diagnosis with functional 
numeracy or comforting themselves that they were maintaining their numbers with 
interpretive numeracy. 
Implications for Nursing Education 
 Nurses at all levels and across many specialties encounter people with diabetes. 
Nurses need to be instructed in use of SMBG as an interface between technology and 
the human experience. SMBG is a psycho-motor skill. The physical performance of 
SMBG was easily performed by patients and nurses alike. Nurses need to learn how to 
use self-regulating interventions with SMBG. Teaching patients how to interpret and use 
SMBG information is a valuable expression of the art and science of nursing. Nurses 
can implement person-centered plans such as the self-regulating SMBG guideline for 
primary care practice (Appendix A) wherever T2DM is diagnosed. Nurses need to be 
taught to frame the communication of diabetes health information while considering the 
functions and meanings of SMBG for people during the first 2 years following T2DM 
diagnosis. Nurses need to be taught to listen and identify the patient‘s illness narrative 
in order to tailor the intervention to the person‘s life-context and to support the ―But now‖ 
of behavior change.  
Research Considerations 
Evaluating the efficacy of SMBG in T2DM has been at best inconclusive (Clar et 
al. 2010). Studies that have examined the relationship between testing and HbA1c have 
not adequately controlled for these different time periods and the impact that a health 
provider has in interpreting and influencing SMBG behaviors and health promoting 
behavior (Clar et al, 2010). Although some studies create models of analysis meant to 
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control for variables such as medication usage, no study could be identified that 
separated out the efficacy of SMBG in the lived time of Diagnosis, Behavior change, or 
Routine (McAndrew et al., 2007) To improve the measurement of the effect of SMBG 
researchers could use these time periods to strengthen future studies by recognizing 
that SMBG is not the same across the T2DM experience. When participants were 
shown Figure 1, they often pointed to a box on the diagram and said, ―This is where I 
am.‖ Researchers could use Figure 1 to identify where participants are in their use of 
SMBG. Studies comparing people who use or do not use SMBG during each of these 
time periods may provide a clearer picture of the efficacy of SMBG in T2DM. 
People initiate SMBG under a wide variety of circumstances. Some people 
initiate testing on their own, others are given glucometers in medical offices without the 
integration of SMBG and diabetes education. Some are instructed in pharmacy 
programs separate from the medical office. None of the SMBG efficacy studies 
examined how people were instructed in the use of SMBG (Clar et al, 2010). In this 
study SMBG was introduced in a framework of problem solving and exploration. 
Variations in the method of framing diabetes education in relation to SMBG likely 
influence the efficacy of SMBG in T2DM. Research on the influence of the framing of 
SMBG education on outcomes is needed to understand the efficacy of SMBG in T2DM.  
Limitations. This study provided detailed information about the experience of 
SMBG and living with T2DM during the first 2 years following diagnosis. The functions 
and meanings of SMBG identified may not be applicable to those who have lived with 
T2DM longer than 2 years. Although limited to rural southern Appalachian participants, 
the processes were similar to those identified in a Sweden, Australia, and Scotland 
132 
 
(Edwall et al., 2008; Furler et al., 2008; Peel et al., 2007). Therefore, some of the 
findings may be more universal than the apparent limitations of this small group of 
participants.  
Strengths. This study is one of few (e.g. Peel et al., 2007; Peel, Parry, Douglas, 
& Lawton, 2004) that consider patient perspectives on SMBG. In addition most of the 
RCTs examining the efficacy of SMBG do not consider the educational context of 
SMBG (Clar et al, 2010). This study was placed in the context of a personalized, self-
regulating SMBG guideline for primary care practice. This study is unique in limiting the 
description to the first 2 years following a diagnosis of diabetes and describing the 
impact of SMBG on diet and exercise.  
One of this study‘s strengths was that the participants knew the researcher. 
Participants were critical of elements of the self-regulating SMBG guideline for primary 
care practice such as wanting to test more often and preferring to test when they could 
achieve a normal value. This criticism indicated a degree of openness in the discourse 
between participant and researcher.  
Many of the participants in this study had storytelling as an important role and 
experience in their families. This made the open ended and narrative form of research 
very comfortable and appropriate for participants. This study differed from other studies 
of SMBG and T2DM because the participants all shared a common diagnosis and 
treatment plan. In addition this was the first study to examine this experience in relation 
to a model of primary, applied, and interpretive numeracy.  
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Conclusions 
“Knowing where I am at”. Once SMBG became routine a common interpretive 
numeracy function was ―knowing where I am at.‖ Participants used numeracy skills in an 
interpretive and holistic sense to define their T2DM experience. This is consistent with 
Polanyi‘s (1966) philosophy of personal knowledge where a person knows more than he 
or she can tell and in which the whole is more instructive than the particulars. When 
participants used SMBG during Routine, the whole was more important than their 
knowledge of the pieces. ―Knowing where I am at‖ a person with T2DM created small 
adjustments in behavior and experienced a feeling of security. Participants were not 
actively applying numerical processes such as counting carbohydrates or timing 
minutes of exercise. Instead, they were using numbers as an estimator to help ―keep 
them in line‖ as they maintained healthy behaviors or restrained unhealthy behaviors. 
 Prior to listening to my participants I had thought that testing in Routine was 
unnecessary because I could not hear the active use of BG readings evident during 
Behavior change. One participant called SMBG ―preventive maintenance‖. Now I 
understand that ―knowing where I am at‖ is important to a person living with T2DM as it 
maintains the person‘s new health behavior and restrains old habits. 
The year following a diagnosis of diabetes appears to be a fertile time for health 
behavior change. People no longer feeling invincible consider other health concerns 
during this time and reflect on how diabetes may impact their life. During Diagnosis, 
SMBG functions to confirm the T2DM and make it real for the participants. Expression 
of anxiety upon receiving the T2DM diagnosis was common and greater in those with 
HbA1c > 7.0%. Participants who could identify one time of day that their readings were 
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on target found that SMBG functioned to comfort them at that time. Once participants 
accepted their diagnosis and believed that they would be ―some kind of O.K.‖, they were 
able to move on to explore how their bodies responded to food, activity, stress, and 
smoking. Successful and less successful experiences as evaluated with SMBG helped 
motivate participants toward action or restraint. In the end SMBG congratulated 
successful managers when they could ―make their numbers.‖ 
 I had begun the research process believing that many people just tested their 
blood glucose without thinking or reacting to the values they received. After listening to 
the participants in this study I learned the important ways that SMBG motivated them to 
continue with behavior change. I now believe that it is the process of implementing 
SMBG that is important to SMBG efficacy. I have concerns that as people have access 
to receiving SMBG devices outside of a healthcare relationship (e.g. pharmacy 
programs, mail order medical equipment suppliers), the testing may not be as 
beneficial. Now pharmacies are required by Medicare to obtain logbooks of BG testing 
results from Medicare recipients. These logs are not discussed or examined for clinical 
purposes. The administrative burden of providing Medicare recipients with more than 
the allowable number of strips (one strip per day for non-insulin-requiring T2DM) has 
prevented me from recommending more frequent testing. I now believe that people 
newly diagnosed with diabetes need more test strips during the 2 years in order to 
establish healthy routines. More study is needed to determine the frequency of testing 
needed during the extended maintenance period in the years that follow diagnosis. 
Perhaps cost savings can be incurred during these years. However, this study found 
that during the first 2 years following a diabetes diagnosis, SMBG initiated in the primary 
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care office with the support of a nurse appears to be influential for forming health beliefs 
and behaviors. SMBG at least once a day could establish a foundation for a lifetime of 
improved diabetes management.  
Participants in this study shared an experience of being diagnosed with diabetes 
in a primary care practice. All participants were exposed to a self-regulating model of 
practice using SMBG to learn more about their diabetes. Participants were asked to use 
SMBG to answer their question, ―Do I really have a problem?‖ They reported that testing 
removed question marks and confirmed their diagnosis. In addition they were asked to 
―Look for trouble.‖ They moved testing around their daily life to evaluate different testing 
circumstances. Participants did not like ―looking for trouble‖ as they preferred to test at 
times when their readings were at target. They liked to know they were, ―some kind of 
O.K.‖ Eventually most participants did begin to explore their bodies‘ response to food 
choices by testing 2 hours after meals. They learned that foods such as spaghetti and 
juice elevated their blood glucose. They considered health behavior changes as they 
made observations and asked questions about their readings. This active application of 
numeracy processes helped them to ―figure out‖ how to control diabetes. For 
participants the SMBG meant that diabetes didn‘t control them, they controlled it. They 
did not want to use SMBG less than once daily as they described testing as a ―daily 
tracking device.‖ Participants used interpretive numeracy processes during Routine. In 
addition the SMBG functioned to motivate participants. The numbers ―made them go 
walking‖ and were interpreted as a reminder of others that did not have favorable 
diabetes health outcomes.  
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Participants made statements that SMBG helped them achieve their goals, 
improve health behavior, improve HbA1c results, and achieve weight loss, although 
they appraised confidence in their future ability to maintain their goals as ―midways‖ on 
a scale of 1 to 10. The participants‘ enthusiasm to use SMBG daily and often and the 
indifferent appraisal of future behavior seems incongruent. However, I believe this 
reflects two different embodiments of illness. SMBG represents the need of the 
disciplined body to have control.  While the appraisal of future ability to maintain health 
behavior represents the need of the communicative body to have other-relatedness 
(Frank, 1995). Actually this ―midways‖ is a healthy response to the monadic limitations 
of the disciplined body. Acknowledging the possibility of not relinquishing oneself to the 
duty and regimen of the disciplined body leaves the person with T2DM able to be open 
to contingencies that may not conform to the prescribed health behavior for people with 
T2DM. Accordingly, ―knowing where I am at‖ may actually facilitate a healthy fluid self 
expression between the desire for control and the need for relatedness.  
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APPENDICES 
Appendix A 
 
Self-Regulating SMBG Guideline for Primary Care Practice 
 
Visit 
#/Day 
Visit Focus SMBG Purpose SMBG Pattern 
Visit 1      
Day 0 
Instruct in SMBG testing. 
Focus on a brief explanation 
of disease process.  
 
Provide target BG for 
fasting/premeal and 2 hours 
after meals. 
 
Purpose: ―Looking for 
trouble‖ and ―Do I 
really have a 
problem?‖ 
 
 
Day 1 Bedtime. 
Day 2 Fasting and 2 hours after Breakfast. 
Day 3 Before mid-day meal and 2 hours 
after mid-day meal. 
Day 4 Before evening meal and 2 hours 
after evening meal. 
Day 5 Off 
Day 6 Off 
Day 7 Off (Patient‘s choice—after exercise? 
After a snack? Stressed?) 
Week 2 Repeat starting at Day 1  
Visit 2     
Day 14 
Identify problem times from 
two weeks of testing. 
 
Focus on Nutritional 
guidelines.  
Set patient centered goals. 
Ask patient to bring a 3 day 
dietary diary to next visit. 
Purpose ―Dietary 
contribution to 
elevated BG‖  
 
Test once daily at problem time for 2 weeks. 
Or 
Test twice daily, before and 2 hours after a 
meal 3 days a week and fasting one day 
following the day that the evening meal was 
tested. 
 
Visit 3   
Day 28 
Review BG results and Diet 
diary. 
 
Ask patient in what ways the 
BG testing and diet diary help 
them in DM self-
management. 
 
Focus on Activity guidelines. 
Set patient centered goals. 
Ask patient to bring activity 
diary to next visit. 
Purpose: ―Does 
testing help me 
achieve my goals?‖ 
 
Set BG testing based on patient answers. 
  
Not helpful: Ask patient to test based on    
practitioner needs.  
 
Helpful: Continue with patient determined 
testing. 
 
 
Visit 4  
Day 90 
Answer patient questions 
Review progress towards 
activity and dietary goals. 
Set patient centered goals 
 
Focus on patient goals 
(activity, dietary, stress 
management).  
Purpose: ―Did 
behavior changes 
improve my BG, my 
weight?‖ 
 
 
Check HbA1c  
 
Set BG testing using Monnier‘s guidelines 
and patient preference. 
 
HbA1c < 6.5 % lifestyle change alone 
HbA1c ≥ 6.5 ≤ 6.9 % consider Metformin 
HbA1c ≥ 7.0% start Metformin 
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Appendix B 
Consent 
EAST TENNESSEE STATE UNIVERSITY 
VETERANS AFFAIRS MEDICAL CENTER 
INSTITUTIONAL REVIEW BOARD 
 
This Informed Consent will explain about being a participant in a research study. It is important 
that you read this material carefully and then decide if you wish to be a volunteer. 
 
PURPOSE:   You have been invited to take part in a research study titled, The Experience of 
Self-Monitoring Blood Glucose for People with Non-Insulin-Requiring Type 2 Diabetes. The 
purpose of this research study is to explore the way that people use blood sugar results to 
manage their diabetes.  Your experience provides a unique perspective on this issue, and will 
help health professionals understand the usefulness of blood glucose testing from the patient’s 
perspective for people with type 2 diabetes. 
 
DURATION: You will be asked to schedule an interview appointment. This research interview 
may last about one hour or longer depending on how much you want to say about the topic of 
blood sugar testing.  
  
PROCEDURES:  The procedures, which will involve you as a research subject, will include talking 
about your experience with blood sugar testing during a research interview. Your interview will 
be recorded using a microphone and a computer.  You will be asked to describe yourself. You 
will be asked to show your blood sugar log (whether you use a written log or keep your 
readings in your blood sugar meter). A photocopy and/or photo of some of the pages/meters 
will be made.  
 
ALTERNATIVE PROCEDURES/TREATMENTS:  This study does not involve a treatment but 
focuses on what you are already doing to test your blood sugar. The alternative is not to 
participate in this study. 
 
POSSIBLE RISKS/DISCOMFORTS:  It is not likely that you will feel uncomfortable talking about 
your experience; but if you feel uncomfortable you can stop the interview at any time. There is 
no reasonable expectation that this research causes risks to fetuses or embryos. 
 
POSSIBLE BENEFITS:  There is no direct benefit to participating in this study. A possible 
benefit from your participation is that you will be informing health providers more about how 
people with diabetes use blood sugar information. Your participation may benefit other people 
with diabetes as we learn from your experience.  
 
FINANCIAL COSTS: There are no additional costs to you as a result of participating in 
this research study.  
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VOLUNTARY PARTICIPATION   
 
Participation in this research experiment is voluntary.   
You may refuse to participate.  You can quit at any time.  If you quit or refuse to 
participate, the benefits to which you are otherwise entitled will not be affected. Participating or 
not participating does not impact your care at Mountain Family Medicine, PA. 
 You may quit by calling Dana Brackney, whose phone number is 828/262-1800.  You 
will be told immediately if any of the results of the study should reasonably be expected to 
make you change your mind about staying in the study.     
 
CONTACT FOR QUESTIONS:  If you have any questions, problems or research-related medical 
problems at any time, you may call Dana Brackney at 828/262-1800; or Kathleen Rayman at 
423/439-4589.  You may call the Chairman of the Institutional Review Board at 423/439-6054 
for any questions you may have about your rights as a research subject.  If you have any 
questions or concerns about the research and want to talk to someone independent of the 
research team or you can’t reach the study staff, you may call an IRB Coordinator at 423/439-
6055 or 423/439-6002. 
 
CONFIDENTIALITY:  Every attempt will be made to see that your study results are kept 
confidential.  A copy of the records from this study will be stored in a locked computer file at 
the researcher’s residence for at least 5 years after the end of this research.  The results of this 
study may be published and/or presented at meetings without naming you as a subject.  
Although your rights and privacy will be maintained, the Secretary of the Department of Health 
and Human Services, and personnel particular to this research have access to the study 
records.  Your medical records will be kept completely confidential according to current legal 
requirements.  They will not be revealed unless required by law, or as noted above. 
 
By signing below, you confirm that you have read or had this document read to you.  You will 
be given a signed copy of this informed consent document.  You have been given the chance to 
ask questions and to discuss your participation with the investigator.  You freely and voluntarily 
choose to be in this research project. By signing below, you confirm that you are giving consent 
to the photographing/photocopying of your blood glucose logbook and/or blood glucose meter 
and the audio recording of your interview. 
 
 
 
SIGNATURE OF PARTICIPANT          DATE 
 
_____________________________________________________________________ 
PRINTED NAME OF PARTICIPANT           DATE 
 
_____________________________________________________________________ 
SIGNATURE OF INVESTIGATOR                 DATE 
 
_____________________________________________________________________ 
SIGNATURE OF WITNESS (if applicable)                DATE 
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Appendix C 
Self Monitoring Blood Glucose Interview Guide 
 
I am interested in learning more about how people who have type 2 diabetes use blood 
sugar testing to help them manage their diabetes. But first I would like to know how you 
found out that you had diabetes. What was that experience like for you?  
Could you tell me what you remember about how you learned to test your 
blood sugar? How do you decide when to test your blood sugar? Do you have target 
blood sugar levels? Do the blood sugar numbers mean anything to you? What advice 
would you give to someone who is just learning about their blood sugar? 
What do you understand about your blood sugar readings? How often do your 
readings surprise you? Can you ever think of an explanation as to why your readings 
are as they are? How does testing your blood sugar effect how you feel about 
yourself or diabetes? What do your readings mean to you? 
Sometimes people learn that a certain feeling means their blood sugar is high or 
low. Do you think that you can tell by a feeling if your blood sugar is high or low? 
Have you ever confirmed your feeling with blood sugar testing? Could you tell me more 
about this experience? 
Do you feel like your doctor or nurse judges you because of your blood 
sugar readings? Why or why not? How does blood sugar testing help you manage 
diabetes? Is there any way that blood sugar testing does not help you? 
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Appendix D  
 
Participant Self-Description  
 
Number 
 
People who live in Western North Carolina have had a variety of life experiences. Some 
people have lived close to where they were born all their life. Other people have moved 
to this area for employment. Some people move here for retirement or other reasons. 
How would you describe yourself? 
 
 
Race 
Gender 
Age 
Insurer 
Years/months with diabetes 
HbA1c 1.  2.  3. 
Medications for diabetes 
Reported blood sugar average pre-meal  
Reported blood sugar average post-meal 
Primary medical manager of diabetes 
 Family Practice 
 Endocrinologist 
 Advanced Practice Nurse 
 Health Department 
 Other 
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